###begin article-title 0
Vitamin D Binding Protein Genotype and Osteoporosis
###end article-title 0
###begin p 1
###xml 1156 1157 1156 1157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1175 1176 1175 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1185 1187 1185 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1206 1207 1206 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1216 1218 1216 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 1283 1284 1283 1284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1285 1286 1285 1286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1621 1622 1621 1622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Osteoporosis is a bone disease leading to an increased fracture risk. It is considered a complex multifactorial genetic disorder with interaction of environmental and genetic factors. As a candidate gene for osteoporosis, we studied vitamin D binding protein (DBP, or group-specific component, Gc), which binds to and transports vitamin D to target tissues to maintain calcium homeostasis through the vitamin D endocrine system. DBP can also be converted to DBP-macrophage activating factor (DBP-MAF), which mediates bone resorption by directly activating osteoclasts. We summarized the genetic linkage structure of the DBP gene. We genotyped two single-nucleotide polymorphisms (SNPs, rs7041 = Glu416Asp and rs4588 = Thr420Lys) in 6,181 elderly Caucasians and investigated interactions of the DBP genotype with vitamin D receptor (VDR) genotype and dietary calcium intake in relation to fracture risk. Haplotypes of the DBP SNPs correspond to protein variations referred to as Gc1s (haplotype 1), Gc2 (haplotype 2), and Gc1f (haplotype3). In a subgroup of 1,312 subjects, DBP genotype was found to be associated with increased and decreased serum 25-(OH)D3 for haplotype 1 (P = 3 x 10-4) and haplotype 2 (P = 3 x 10-6), respectively. Similar associations were observed for 1,25-(OH)2D3. The DBP genotype was not significantly associated with fracture risk in the entire study population. Yet, we observed interaction between DBP and VDR haplotypes in determining fracture risk. In the DBP haplotype 1-carrier group, subjects of homozygous VDR block 5-haplotype 1 had 33% increased fracture risk compared to noncarriers (P = 0.005). In a subgroup with dietary calcium intake <1.09 g/day, the hazard ratio (95% confidence interval) for fracture risk of DBP hap1-homozygote versus noncarrier was 1.47 (1.06-2.05). All associations were independent of age and gender. Our study demonstrated that the genetic effect of the DBP gene on fracture risk appears only in combination with other genetic and environmental risk factors for bone metabolism.
###end p 1
###begin title 2
Keywords
###end title 2
###begin p 3
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 457 458 457 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 459 460 459 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
Osteoporosis is defined as a reduction in bone mass deterioration of bone microarchitecture, resulting in increased bone fragility and increased fracture risk [1]. It is a complex disorder with interaction between environmental (e.g., low calcium intake) and genetic factors. Several genetic association studies have demonstrated a relationship between polymorphisms of candidate genes with decreased bone mineral density (BMD) and increased fracture risk [2-7].
###end p 3
###begin p 4
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 636 637 636 637 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 646 647 646 647 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 711 712 711 712 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 722 723 722 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 724 725 724 725 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 805 806 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 810 811 810 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 1055 1057 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 1063 1069 1063 1069 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 1185 1186 1185 1186 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1328 1331 1328 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 1510 1516 1510 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle</italic>
###xml 1574 1585 1574 1585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 1874 1875 1874 1875 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2008 2023 2008 2023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vertical arrows</italic>
###xml 1069 2202 1069 2202 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="5">Functional domain of the Gc protein and haplotype structure and allele frequencies in different ethnic populations. <bold>a</bold> The triple domain structure of the Gc protein and the haplotype structure of the DBP (Gc) gene. Three domains of the Gc protein are shown at <italic>top</italic>; domain I is the vitamin D binding domain. Domains II and III are non-sterol binding activity domains. Domain III is related to macrophage/osteoclast activating activity. In the <italic>middle</italic> we present the genomic structure of the DBP gene. In the <italic>lower panel</italic>, we present the haplotype structures of the DBP gene in a Caucasian population according to the HapMap data. The gray double-headed arrows indicate LD blocks in a population. The LD structure is defined according to 50 genotyped SNPs of the population in the region from the HapMap data. <bold>b</bold> Haplotype structure and allele frequency comparison according to SNPs E416D (rs7041) and T420K (rs4588) in exon 11 of the DBP gene. <italic>Vertical arrows</italic> indicate two nonsynonymous SNPs. Haplotype and protein variation alleles are in the left panel. Allele frequencies of haplotypes were calculated in the Rotterdam Study population</p>
###xml 1069 2202 1069 2202 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="5">Functional domain of the Gc protein and haplotype structure and allele frequencies in different ethnic populations. <bold>a</bold> The triple domain structure of the Gc protein and the haplotype structure of the DBP (Gc) gene. Three domains of the Gc protein are shown at <italic>top</italic>; domain I is the vitamin D binding domain. Domains II and III are non-sterol binding activity domains. Domain III is related to macrophage/osteoclast activating activity. In the <italic>middle</italic> we present the genomic structure of the DBP gene. In the <italic>lower panel</italic>, we present the haplotype structures of the DBP gene in a Caucasian population according to the HapMap data. The gray double-headed arrows indicate LD blocks in a population. The LD structure is defined according to 50 genotyped SNPs of the population in the region from the HapMap data. <bold>b</bold> Haplotype structure and allele frequency comparison according to SNPs E416D (rs7041) and T420K (rs4588) in exon 11 of the DBP gene. <italic>Vertical arrows</italic> indicate two nonsynonymous SNPs. Haplotype and protein variation alleles are in the left panel. Allele frequencies of haplotypes were calculated in the Rotterdam Study population</p></caption>
###xml 2202 2202 2202 2202 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="223_2009_9251_Fig1_HTML" id="MO1"/>
###xml 1063 2202 1063 2202 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="5">Functional domain of the Gc protein and haplotype structure and allele frequencies in different ethnic populations. <bold>a</bold> The triple domain structure of the Gc protein and the haplotype structure of the DBP (Gc) gene. Three domains of the Gc protein are shown at <italic>top</italic>; domain I is the vitamin D binding domain. Domains II and III are non-sterol binding activity domains. Domain III is related to macrophage/osteoclast activating activity. In the <italic>middle</italic> we present the genomic structure of the DBP gene. In the <italic>lower panel</italic>, we present the haplotype structures of the DBP gene in a Caucasian population according to the HapMap data. The gray double-headed arrows indicate LD blocks in a population. The LD structure is defined according to 50 genotyped SNPs of the population in the region from the HapMap data. <bold>b</bold> Haplotype structure and allele frequency comparison according to SNPs E416D (rs7041) and T420K (rs4588) in exon 11 of the DBP gene. <italic>Vertical arrows</italic> indicate two nonsynonymous SNPs. Haplotype and protein variation alleles are in the left panel. Allele frequencies of haplotypes were calculated in the Rotterdam Study population</p></caption><graphic position="anchor" xlink:href="223_2009_9251_Fig1_HTML" id="MO1"/></fig>
###xml 48 56 <span type="species:ncbi:9606">children</span>
A deficiency of vitamin D results in rickets in children and osteomalacia in adults and increases risk of osteoporosis [8]. Vitamin D binding protein (DBP) was initially named group-specific component (Gc) and is a serum protein with differential functions. Two functions of DBP involve skeletal metabolism: The first one is through the vitamin D endocrine system. Vitamin D is an important cofactor of calcium absorption in intestine and reabsorption in kidney, which plays an essential role in regulating serum calcium and phosphate homeostasis as well as bone metabolism. DBP binds to vitamin D metabolites (e.g., 25-hydroxyvitamin D3 [25(OH)D3], the major circulating metabolite, and 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], the active form of vitamin D) at the sterol binding domain (domain I in Fig. 1a) [9]; transports vitamin D to liver, kidney, bone, and other target tissues; and stores and prolongs the half-life of the circulating vitamin D metabolites [10]. Vitamin D metabolites are strongly and positively correlated to DBP levels in serum [11, 12].Fig. 1Functional domain of the Gc protein and haplotype structure and allele frequencies in different ethnic populations. a The triple domain structure of the Gc protein and the haplotype structure of the DBP (Gc) gene. Three domains of the Gc protein are shown at top; domain I is the vitamin D binding domain. Domains II and III are non-sterol binding activity domains. Domain III is related to macrophage/osteoclast activating activity. In the middle we present the genomic structure of the DBP gene. In the lower panel, we present the haplotype structures of the DBP gene in a Caucasian population according to the HapMap data. The gray double-headed arrows indicate LD blocks in a population. The LD structure is defined according to 50 genotyped SNPs of the population in the region from the HapMap data. b Haplotype structure and allele frequency comparison according to SNPs E416D (rs7041) and T420K (rs4588) in exon 11 of the DBP gene. Vertical arrows indicate two nonsynonymous SNPs. Haplotype and protein variation alleles are in the left panel. Allele frequencies of haplotypes were calculated in the Rotterdam Study population
###end p 4
###begin p 5
###xml 116 117 116 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 259 262 259 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">top</italic>
###xml 441 447 441 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">middle</italic>
###xml 505 516 505 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower panel</italic>
###xml 805 806 805 806 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 939 954 939 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vertical arrows</italic>
Functional domain of the Gc protein and haplotype structure and allele frequencies in different ethnic populations. a The triple domain structure of the Gc protein and the haplotype structure of the DBP (Gc) gene. Three domains of the Gc protein are shown at top; domain I is the vitamin D binding domain. Domains II and III are non-sterol binding activity domains. Domain III is related to macrophage/osteoclast activating activity. In the middle we present the genomic structure of the DBP gene. In the lower panel, we present the haplotype structures of the DBP gene in a Caucasian population according to the HapMap data. The gray double-headed arrows indicate LD blocks in a population. The LD structure is defined according to 50 genotyped SNPs of the population in the region from the HapMap data. b Haplotype structure and allele frequency comparison according to SNPs E416D (rs7041) and T420K (rs4588) in exon 11 of the DBP gene. Vertical arrows indicate two nonsynonymous SNPs. Haplotype and protein variation alleles are in the left panel. Allele frequencies of haplotypes were calculated in the Rotterdam Study population
###end p 5
###begin p 6
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
The vitamin D receptor (VDR) mediates the action of the vitamin D endocrine system in calcium homeostasis and bone metabolism. In a previous study, we demonstrated that the haplotype 1 allele of linkage disequilibrium (LD) block 5, including variations in the 3'-untranslated region (UTR) of the VDR gene, are associated with increased fracture risk. This allele decreases the VDR mRNA level by 15% in osteoblast cells [13].
###end p 6
###begin p 7
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 970 972 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 424 428 <span type="species:ncbi:10116">rats</span>
###xml 807 811 <span type="species:ncbi:10116">rats</span>
Besides its role in vitamin D metabolism, serum DBP can also be converted to a DBP-macrophage activating factor (DBP-MAF) by the deglycosylation of DBP at the non-sterol binding domain (domain III in Fig. 1a), which involves the osteoclast activating domain [14, 15]. DBP-MAF plays a role in osteoclast differentiation [16] and mediates bone resorption by directly activating osteoclasts [14]. DBP-MAF-treated osteopetrosis rats have increased number and activity of osteoclasts and decreased bone mass [17]. Hence, the contribution of DBP to bone metabolism is not only through assisting the vitamin D endocrine system but also directly influencing bone resorption. In addition, there is evidence to suggest an interaction of DBP with calcium intake. The number of osteoclasts significantly increases when rats are in a calcium deficiency condition, and the osteoclast number returned to a similar level as control groups after calcium or phosphorus replenishment [18, 19]. Thus, both DBP-MAF and low calcium intake can influence osteoclast number and activity.
###end p 7
###begin p 8
Thus, DBP and the vitamin D-VDR system might influence bone resorption (via osteoclasts) and bone formation (via osteoblasts), respectively, which could result in osteoporosis.
###end p 8
###begin p 9
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 559 561 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
The three most commonly studied protein variations are identified by two polymorphisms in exon 11: a G/A substitution at codon 416 (E416D), leading to a Glu/Asp amino acid change, and a C/A substitution at codon 420 (T420K), leading to a Thr/Lys amino acid change [20]. Haplotypes of the nucleotide changes result in the protein isoforms Gc1s, Gc2, and Gc1f (Fig. 1b). Recently, two studies demonstrated a relationship between a DBP haplotype (or protein isoform, Gc1) with decreased BMD and increased fracture risk in Japanese and Caucasian populations [21, 22].
###end p 9
###begin p 10
Since both DBP and VDR gene are involved in the vitamin D endocrine pathway, which is one of the key systems of osteoporosis, no studies so far have addressed the genetic interaction between VDR and DBP gene variants on osteoporosis risk; and neither has the interaction been studied between serum level of DBP and dietary calcium intake in relation to osteoporosis. In this study, we studied genetic variants in the DBP gene in relation to osteoporosis risk, gene-gene interaction (DBP-VDR, the interaction of genes encoding vitamin D transporter and receptor in the vitamin D endocrine pathway), as well as gene-environmental interaction (DBP gene variants vs. dietary calcium intake, both involving osteoclast activity) in relation to the risk of osteoporosis in a large-scale population-based cohort (the Rotterdam Study).
###end p 10
###begin title 11
Materials and Methods
###end title 11
###begin title 12
Subjects
###end title 12
###begin title 13
The Rotterdam Study Population
###end title 13
###begin p 14
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 737 738 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 146 149 <span type="species:ncbi:9606">men</span>
###xml 168 173 <span type="species:ncbi:9606">women</span>
The Rotterdam Study is a single-center prospective population-based cohort study and includes 7,983 (>55 years) Caucasian individuals, with 3,105 men (38.9%) and 4,878 women (61.1%), to analyze the determinants and prognosis of chronic and disabling diseases in the elderly [23]. The baseline measurements were performed between 1990 and 1993. For the current study, 6,580 DNA samples (82.4% of the whole cohort population) were available, and 6,181 individuals were successfully genotyped for DBP SNPs, including 6,009 subjects being successfully genotyped for both DBB and VDR genotypes. For 4,747 out of 6,181 subjects, data on dietary calcium intake were available. Of the 6,181 subjects, 5,931 had baseline measurements of BMD (g/cm2). At baseline, for 1,317 (of 6,181) subjects we measured serum vitamin D level.
###end p 14
###begin title 15
DNA Isolation and Genotyping
###end title 15
###begin p 16
###xml 420 422 420 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 430 433 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 484 486 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">TM</sup>
###xml 597 600 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 638 641 633 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 725 726 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 953 956 925 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 976 979 946 947 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
Genomic DNA was isolated from peripheral venous blood specimens according to standard protocols. In the DBP gene we genotyped two single nucleotide polymorphisms (SNPs) in exon 11, E416D and T420K, which change the amino acid sequence at codons 416 and 420, respectively. The genotyping was detected with Taqman assays from Applied Biosystems (ABI; Foster City, CA). The assay mixes (including unlabeled PCR primers, FAMTM and VIC(R) dye-labeled TaqMan MGB probes) of Assays-by-DesignTM were designed and supported by ABI. The reaction system contained 2 ng of dried genomic DNA, 2.5 muL of TaqMan(R) Universal PCR Master Mix, No AmpErase(R) UNG (2x), 0.125 muL (40x), or 0.0625 muL (80x) of Assay Mix, and adjusted Milli-Q H2O in a total volume of 5 muL. The reaction conditions consisted of an initial step at 95degreesC for 10 min, followed by 40 cycles at 92degreesC for 15 s and 60degreesC for 60 s in a 384-well plate using PCR machines, ABI Prism(R) 7900HT, ABI GeneAmp(R) PCR system 9700, or PTC-225 Peltier Thermal Cycler (MJ Research, Watertown, MA). The genotyping results were analyzed by end point reading in the ABI Prism 7900HT, determined independently by two operators; and 5% random samples were regenotyped to check for genotyping errors. No inconsistencies were observed.
###end p 16
###begin title 17
LD and Haplotype Analyses
###end title 17
###begin p 18
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
We first compared LD structures of the DBP gene for the Caucasian population with the HapMap database (Release 23a/phase II March 2008, on NCBI B36, dbSNP b126) [24] (Fig. 1a). We selected SNPs with a minor allele frequency >10%, and identified 50 SNPs. (The haplotypes of E416D and T420K SNPs in the Rotterdam Study population were generated by the PHASE program [25]).
###end p 18
###begin title 19
Clinical Data for the Association Study
###end title 19
###begin p 20
###xml 821 822 821 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 834 835 834 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 478 490 <span type="species:ncbi:9606">participants</span>
Information on medical history, dietary habits, age at menopause, and smoking was obtained with a computerized questionnaire during a home interview at baseline. Intakes of calcium and total energy were calculated by food-frequency questionnaire (based on all food and drinks consumed in 1 month) with the use of Dutch food-composition tables. We calculated the total dietary energy intake and adjusted dietary calcium intake for all individuals. Anthropometric measurements of participants were obtained at the research center. Height (cm) and weight (kg) were measured in the standing position in indoor clothing without shoes, and all height measurements were obtained by a research assistant using a standard wall-mounted station-meter. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m2). BMD (g/cm2) was determined by dual-energy X-ray absorptiometry (DXA, Lunar DPX-L densitometer; Lunar Radiation, Madison, WI) at the femoral neck and lumbar spine (vertebrae L2-L4) as described before [26].
###end p 20
###begin title 21
Assessment of Fracture
###end title 21
###begin p 22
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
We defined fracture as described before [5, 27, 28]. All fractures were confirmed by general practitioners or hospitals and included hip, vertebral, wrist, and other fractures but excluded head, foot, hand, and pathological postprocedural skull and face fractures. The incidence of fracture was considered as new cases diagnosed during the follow-up period (7.4 +/- 3.3 years). The latest follow-up period ended January 1, 2002.
###end p 22
###begin title 23
Vitamin D Measurement
###end title 23
###begin p 24
###xml 153 154 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 167 168 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 169 170 162 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 380 381 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 394 395 387 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 396 397 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 328 335 <span type="species:ncbi:9606">patient</span>
A total of 50 muL serum obtained at baseline was stored at -20degreesC and used for the quantitative determination of total (free and bound form) 25(OH)D3 and 1,25(OH)2D3 levels with radioimmunoassay kits from Immunodiagnostic Systems (Boldon, UK). The assays for vitamin D measurement are routine assays used in the clinic for patient diagnostics. Three concentrations of 25(OH)D3 and 1,25(OH)2D3 were tested with an average VC of 5.7 and 6.6%, respectively.
###end p 24
###begin title 25
Statistical and Association Analyses
###end title 25
###begin p 26
###xml 341 342 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
All genotyping results were tested for Hardy-Weinberg equilibrium (HWE). We applied one-way analysis of variance (ANOVA) to investigate the relationship between genotypes and age, height, weight, BMD, BMD loss, bone geometry variables, serum vitamin D level, dietary calcium intake, and other continuous outcomes. We employed the Pearson chi2 test and calculated the hazard ratio (HR) and 95% confidence interval (95% CI) with the Cox regression model to investigate the relationship between incidence of clinical fracture and haplotypes of the DBP gene. To check the proportional hazard assumption of the Cox model, we plotted the Kaplan-Meier observed hazard curve and compared it to the Cox predicted curve. When the predicted and observed values were close together, the proportional hazard assumption had not been violated. Both analysis of covariance (ANCOVA) and Cox models were adjusted for potential confounders, such as age, gender, height, weight, BMD, and dietary calcium intake. We also stratified the analyses by gender and high/low calcium intake according to the median, tertiles, and quartiles of dietary calcium intake in the study population. The gene-gene and gene-environmental interactions of VDR genotype and calcium intake with DBP genotype for fracture risk were first estimated in linear regression models with adjustment for age and gender; we then compared (1) the pattern difference of the association of VDR genotype with fracture risk by DBP genotypes and (2) the pattern difference of the association of DBP haplotype with fracture risk by low or high calcium intake groups. All statistical analyses of the association study were carried out with the SPSS software package (version 14; SPSS, Inc., Chicago, IL).
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
Genomic and Haplotype Structures of the DBP Gene
###end title 28
###begin p 29
###xml 91 92 91 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 955 956 955 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
The DBP gene is at least 42 kb in length, contains 12 exons with a 4.3 kb 3'-UTR (see Fig. 1a), and has at least 295 SNPs according to dbSNP (build 129) [29]. We studied the LD structure of the DBP gene for the Caucasian population with SNP (minor allele frequency >10%) genotype data of the HapMap [24]. There are three LD blocks present in the DBP gene. Two SNPs, E416D and T420K in exon 11, are located in domain III (an osteoclast activating domain) and are genetically independent of LD block(s) in domain I (vitamin D binding domain). This suggests that these two SNPs in domain III might have genetic function(s) independent of other domains. Because of high linkage between these two SNPs, only three instead of the possible four haplotypes were present in our population, corresponding to three Gc isoforms distinguished at the protein level. The allele frequencies of the different haplotypes in the Rotterdam Study population are shown in Fig. 1b.
###end p 29
###begin title 30
Association Studies of DBP Haplotypes
###end title 30
###begin title 31
Serum Vitamin D Level
###end title 31
###begin p 32
###xml 49 50 49 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 156 157 156 157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 170 171 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 271 272 267 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 379 380 375 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 382 383 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 392 394 388 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 465 466 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 467 468 461 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 470 471 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 480 482 474 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 613 614 605 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 616 617 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 626 628 618 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 661 662 651 652 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 663 664 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 666 667 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 676 678 666 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 949 956 939 946 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 956 1075 946 1065 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="33">Serum vitamin D level by haplotypes of DBP (Gc) codon 416&#8211;420 in a subset of elderly men and women of the entire cohort</p>
###xml 956 1075 946 1065 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="33">Serum vitamin D level by haplotypes of DBP (Gc) codon 416&#8211;420 in a subset of elderly men and women of the entire cohort</p></caption>
###xml 1075 1075 1065 1065 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"/>
###xml 1075 1101 1065 1089 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Mean&#160;&#177;&#160;SD (total number)</th>
###xml 1101 1135 1089 1123 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3">By haplotypes of DBP codon 416&#8211;420</th>
###xml 1135 1165 1123 1153 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Noncarrier vs. homozygous (SD)</th>
###xml 1165 1166 1153 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1166 1167 1154 1155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 1165 1167 1153 1155 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"><italic>P</italic><sup>#</sup></th>
###xml 1075 1167 1065 1155 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2"/><th align="left" rowspan="2">Mean&#160;&#177;&#160;SD (total number)</th><th align="left" colspan="3">By haplotypes of DBP codon 416&#8211;420</th><th align="left" rowspan="2">Noncarrier vs. homozygous (SD)</th><th align="left" rowspan="2"><italic>P</italic><sup>#</sup></th></tr>
###xml 1167 1177 1155 1165 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Noncarrier</th>
###xml 1177 1189 1165 1177 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Heterozygous</th>
###xml 1189 1199 1177 1187 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Homozygous</th>
###xml 1167 1199 1155 1187 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr>
###xml 1075 1199 1065 1187 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Mean&#160;&#177;&#160;SD (total number)</th><th align="left" colspan="3">By haplotypes of DBP codon 416&#8211;420</th><th align="left" rowspan="2">Noncarrier vs. homozygous (SD)</th><th align="left" rowspan="2"><italic>P</italic><sup>#</sup></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead>
###xml 1206 1207 1194 1195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1199 1216 1187 1204 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25-OH-D<sub>3</sub> (nmol/l)</td>
###xml 1216 1236 1204 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">65.5&#160;&#177;&#160;27.3 (1312)</td>
###xml 1236 1236 1222 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1236 1236 1222 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1236 1236 1222 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1236 1236 1222 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1236 1236 1222 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1199 1236 1187 1222 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">25-OH-D<sub>3</sub> (nmol/l)</td><td char="&#177;" align="char">65.5&#160;&#177;&#160;27.3 (1312)</td><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td align="left"/><td align="left"/></tr>
###xml 1236 1253 1222 1239 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td>
###xml 1253 1253 1239 1239 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1253 1272 1239 1256 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">61.1&#160;&#177;&#160;26.3 (269)</td>
###xml 1272 1291 1256 1273 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">65.4&#160;&#177;&#160;26.9 (647)</td>
###xml 1291 1310 1273 1290 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">68.5&#160;&#177;&#160;28.3 (396)</td>
###xml 1310 1326 1290 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8593; 0.3</td>
###xml 1332 1334 1301 1303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1326 1335 1295 1304 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td>
###xml 1236 1335 1222 1304 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">61.1&#160;&#177;&#160;26.3 (269)</td><td char="&#177;" align="char">65.4&#160;&#177;&#160;26.9 (647)</td><td char="&#177;" align="char">68.5&#160;&#177;&#160;28.3 (396)</td><td char="." align="char">&#8593; 0.3</td><td align="left">3&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td></tr>
###xml 1335 1350 1304 1319 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td>
###xml 1350 1350 1319 1319 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1350 1369 1319 1336 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">74.2&#160;&#177;&#160;28.3 (665)</td>
###xml 1369 1388 1336 1353 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">63.0&#160;&#177;&#160;25.6 (540)</td>
###xml 1388 1407 1353 1370 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">58.5&#160;&#177;&#160;27.1 (107)</td>
###xml 1407 1425 1370 1375 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8595; 0.6</td>
###xml 1431 1433 1381 1383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 1425 1434 1375 1384 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3&#160;&#215;&#160;10<sup>&#8722;6</sup>*</td>
###xml 1335 1434 1304 1384 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">74.2&#160;&#177;&#160;28.3 (665)</td><td char="&#177;" align="char">63.0&#160;&#177;&#160;25.6 (540)</td><td char="&#177;" align="char">58.5&#160;&#177;&#160;27.1 (107)</td><td char="." align="char">&#8595; 0.6</td><td align="left">3&#160;&#215;&#160;10<sup>&#8722;6</sup>*</td></tr>
###xml 1434 1450 1384 1400 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td>
###xml 1450 1450 1400 1400 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1450 1469 1400 1417 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">65.0&#160;&#177;&#160;27.2 (917)</td>
###xml 1469 1488 1417 1434 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">66.7&#160;&#177;&#160;27.6 (360)</td>
###xml 1488 1506 1434 1450 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">64.9&#160;&#177;&#160;27.1 (35)</td>
###xml 1506 1526 1450 1457 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8595; 0.004</td>
###xml 1526 1530 1457 1461 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.57</td>
###xml 1434 1530 1384 1461 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">65.0&#160;&#177;&#160;27.2 (917)</td><td char="&#177;" align="char">66.7&#160;&#177;&#160;27.6 (360)</td><td char="&#177;" align="char">64.9&#160;&#177;&#160;27.1 (35)</td><td char="." align="char">&#8595; 0.004</td><td align="left">0.57</td></tr>
###xml 1539 1540 1470 1471 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1542 1543 1473 1474 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1530 1552 1461 1483 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1,25-(OH)<sub>2</sub>-D<sub>3</sub> (pmol/l)</td>
###xml 1552 1574 1483 1503 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">109.3&#160;&#177;&#160;30.3 (1,317)</td>
###xml 1574 1574 1503 1503 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1574 1574 1503 1503 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1574 1574 1503 1503 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1574 1574 1503 1503 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1574 1574 1503 1503 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1530 1574 1461 1503 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">1,25-(OH)<sub>2</sub>-D<sub>3</sub> (pmol/l)</td><td char="&#177;" align="char">109.3&#160;&#177;&#160;30.3 (1,317)</td><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="." align="char"/><td align="left"/></tr>
###xml 1574 1591 1503 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td>
###xml 1591 1591 1520 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1591 1611 1520 1538 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">103.7&#160;&#177;&#160;29.1 (270)</td>
###xml 1611 1631 1538 1556 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">109.8&#160;&#177;&#160;30.8 (648)</td>
###xml 1631 1651 1556 1574 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">112.4&#160;&#177;&#160;29.9 (399)</td>
###xml 1651 1667 1574 1579 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8593; 0.3</td>
###xml 1673 1675 1585 1587 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 1667 1676 1579 1588 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td>
###xml 1574 1676 1503 1588 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">103.7&#160;&#177;&#160;29.1 (270)</td><td char="&#177;" align="char">109.8&#160;&#177;&#160;30.8 (648)</td><td char="&#177;" align="char">112.4&#160;&#177;&#160;29.9 (399)</td><td char="." align="char">&#8593; 0.3</td><td align="left">4&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td></tr>
###xml 1676 1691 1588 1603 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td>
###xml 1691 1691 1603 1603 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1691 1711 1603 1621 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">113.0&#160;&#177;&#160;30.9 (668)</td>
###xml 1711 1731 1621 1639 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">105.6&#160;&#177;&#160;29.2 (541)</td>
###xml 1731 1751 1639 1657 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">105.7&#160;&#177;&#160;28.9 (108)</td>
###xml 1751 1769 1657 1662 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8595; 0.2</td>
###xml 1775 1777 1668 1670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 1769 1777 1662 1670 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5&#160;&#215;&#160;10<sup>&#8722;5</sup></td>
###xml 1676 1777 1588 1670 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">113.0&#160;&#177;&#160;30.9 (668)</td><td char="&#177;" align="char">105.6&#160;&#177;&#160;29.2 (541)</td><td char="&#177;" align="char">105.7&#160;&#177;&#160;28.9 (108)</td><td char="." align="char">&#8595; 0.2</td><td align="left">5&#160;&#215;&#160;10<sup>&#8722;5</sup></td></tr>
###xml 1777 1793 1670 1686 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td>
###xml 1793 1793 1686 1686 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char"/>
###xml 1793 1813 1686 1704 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">108.9&#160;&#177;&#160;29.7 (922)</td>
###xml 1813 1833 1704 1722 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">111.0&#160;&#177;&#160;31.5 (360)</td>
###xml 1833 1852 1722 1739 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="&#xB1;" align="char">102.0&#160;&#177;&#160;32.2 (35)</td>
###xml 1852 1870 1739 1744 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">&#8595; 0.2</td>
###xml 1870 1874 1744 1748 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.18</td>
###xml 1777 1874 1670 1748 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">108.9&#160;&#177;&#160;29.7 (922)</td><td char="&#177;" align="char">111.0&#160;&#177;&#160;31.5 (360)</td><td char="&#177;" align="char">102.0&#160;&#177;&#160;32.2 (35)</td><td char="." align="char">&#8595; 0.2</td><td align="left">0.18</td></tr>
###xml 1199 1874 1187 1748 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">25-OH-D<sub>3</sub> (nmol/l)</td><td char="&#177;" align="char">65.5&#160;&#177;&#160;27.3 (1312)</td><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">61.1&#160;&#177;&#160;26.3 (269)</td><td char="&#177;" align="char">65.4&#160;&#177;&#160;26.9 (647)</td><td char="&#177;" align="char">68.5&#160;&#177;&#160;28.3 (396)</td><td char="." align="char">&#8593; 0.3</td><td align="left">3&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">74.2&#160;&#177;&#160;28.3 (665)</td><td char="&#177;" align="char">63.0&#160;&#177;&#160;25.6 (540)</td><td char="&#177;" align="char">58.5&#160;&#177;&#160;27.1 (107)</td><td char="." align="char">&#8595; 0.6</td><td align="left">3&#160;&#215;&#160;10<sup>&#8722;6</sup>*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">65.0&#160;&#177;&#160;27.2 (917)</td><td char="&#177;" align="char">66.7&#160;&#177;&#160;27.6 (360)</td><td char="&#177;" align="char">64.9&#160;&#177;&#160;27.1 (35)</td><td char="." align="char">&#8595; 0.004</td><td align="left">0.57</td></tr><tr><td align="left">1,25-(OH)<sub>2</sub>-D<sub>3</sub> (pmol/l)</td><td char="&#177;" align="char">109.3&#160;&#177;&#160;30.3 (1,317)</td><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="." align="char"/><td align="left"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">103.7&#160;&#177;&#160;29.1 (270)</td><td char="&#177;" align="char">109.8&#160;&#177;&#160;30.8 (648)</td><td char="&#177;" align="char">112.4&#160;&#177;&#160;29.9 (399)</td><td char="." align="char">&#8593; 0.3</td><td align="left">4&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">113.0&#160;&#177;&#160;30.9 (668)</td><td char="&#177;" align="char">105.6&#160;&#177;&#160;29.2 (541)</td><td char="&#177;" align="char">105.7&#160;&#177;&#160;28.9 (108)</td><td char="." align="char">&#8595; 0.2</td><td align="left">5&#160;&#215;&#160;10<sup>&#8722;5</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">108.9&#160;&#177;&#160;29.7 (922)</td><td char="&#177;" align="char">111.0&#160;&#177;&#160;31.5 (360)</td><td char="&#177;" align="char">102.0&#160;&#177;&#160;32.2 (35)</td><td char="." align="char">&#8595; 0.2</td><td align="left">0.18</td></tr></tbody>
###xml 1075 1874 1065 1748 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Mean&#160;&#177;&#160;SD (total number)</th><th align="left" colspan="3">By haplotypes of DBP codon 416&#8211;420</th><th align="left" rowspan="2">Noncarrier vs. homozygous (SD)</th><th align="left" rowspan="2"><italic>P</italic><sup>#</sup></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead><tbody><tr><td align="left">25-OH-D<sub>3</sub> (nmol/l)</td><td char="&#177;" align="char">65.5&#160;&#177;&#160;27.3 (1312)</td><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">61.1&#160;&#177;&#160;26.3 (269)</td><td char="&#177;" align="char">65.4&#160;&#177;&#160;26.9 (647)</td><td char="&#177;" align="char">68.5&#160;&#177;&#160;28.3 (396)</td><td char="." align="char">&#8593; 0.3</td><td align="left">3&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">74.2&#160;&#177;&#160;28.3 (665)</td><td char="&#177;" align="char">63.0&#160;&#177;&#160;25.6 (540)</td><td char="&#177;" align="char">58.5&#160;&#177;&#160;27.1 (107)</td><td char="." align="char">&#8595; 0.6</td><td align="left">3&#160;&#215;&#160;10<sup>&#8722;6</sup>*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">65.0&#160;&#177;&#160;27.2 (917)</td><td char="&#177;" align="char">66.7&#160;&#177;&#160;27.6 (360)</td><td char="&#177;" align="char">64.9&#160;&#177;&#160;27.1 (35)</td><td char="." align="char">&#8595; 0.004</td><td align="left">0.57</td></tr><tr><td align="left">1,25-(OH)<sub>2</sub>-D<sub>3</sub> (pmol/l)</td><td char="&#177;" align="char">109.3&#160;&#177;&#160;30.3 (1,317)</td><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="." align="char"/><td align="left"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">103.7&#160;&#177;&#160;29.1 (270)</td><td char="&#177;" align="char">109.8&#160;&#177;&#160;30.8 (648)</td><td char="&#177;" align="char">112.4&#160;&#177;&#160;29.9 (399)</td><td char="." align="char">&#8593; 0.3</td><td align="left">4&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">113.0&#160;&#177;&#160;30.9 (668)</td><td char="&#177;" align="char">105.6&#160;&#177;&#160;29.2 (541)</td><td char="&#177;" align="char">105.7&#160;&#177;&#160;28.9 (108)</td><td char="." align="char">&#8595; 0.2</td><td align="left">5&#160;&#215;&#160;10<sup>&#8722;5</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">108.9&#160;&#177;&#160;29.7 (922)</td><td char="&#177;" align="char">111.0&#160;&#177;&#160;31.5 (360)</td><td char="&#177;" align="char">102.0&#160;&#177;&#160;32.2 (35)</td><td char="." align="char">&#8595; 0.2</td><td align="left">0.18</td></tr></tbody></table>
###xml 1874 1977 1748 1849 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34">Data are presented as mean&#160;&#177;&#160;SD (number of subjects). Vitamin D level was adjusted for age and gender</p>
###xml 1977 1978 1849 1850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 1978 1979 1850 1851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1977 2049 1849 1921 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35"><sup>#</sup><italic>P</italic> value for trend (*&#160;estimated by linear regression analysis) and ANOVA</p>
###xml 1874 2049 1748 1921 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34">Data are presented as mean&#160;&#177;&#160;SD (number of subjects). Vitamin D level was adjusted for age and gender</p><p textid="35"><sup>#</sup><italic>P</italic> value for trend (*&#160;estimated by linear regression analysis) and ANOVA</p></table-wrap-foot>
###xml 949 2049 939 1921 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="33">Serum vitamin D level by haplotypes of DBP (Gc) codon 416&#8211;420 in a subset of elderly men and women of the entire cohort</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Mean&#160;&#177;&#160;SD (total number)</th><th align="left" colspan="3">By haplotypes of DBP codon 416&#8211;420</th><th align="left" rowspan="2">Noncarrier vs. homozygous (SD)</th><th align="left" rowspan="2"><italic>P</italic><sup>#</sup></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead><tbody><tr><td align="left">25-OH-D<sub>3</sub> (nmol/l)</td><td char="&#177;" align="char">65.5&#160;&#177;&#160;27.3 (1312)</td><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td align="left"/><td align="left"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">61.1&#160;&#177;&#160;26.3 (269)</td><td char="&#177;" align="char">65.4&#160;&#177;&#160;26.9 (647)</td><td char="&#177;" align="char">68.5&#160;&#177;&#160;28.3 (396)</td><td char="." align="char">&#8593; 0.3</td><td align="left">3&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">74.2&#160;&#177;&#160;28.3 (665)</td><td char="&#177;" align="char">63.0&#160;&#177;&#160;25.6 (540)</td><td char="&#177;" align="char">58.5&#160;&#177;&#160;27.1 (107)</td><td char="." align="char">&#8595; 0.6</td><td align="left">3&#160;&#215;&#160;10<sup>&#8722;6</sup>*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">65.0&#160;&#177;&#160;27.2 (917)</td><td char="&#177;" align="char">66.7&#160;&#177;&#160;27.6 (360)</td><td char="&#177;" align="char">64.9&#160;&#177;&#160;27.1 (35)</td><td char="." align="char">&#8595; 0.004</td><td align="left">0.57</td></tr><tr><td align="left">1,25-(OH)<sub>2</sub>-D<sub>3</sub> (pmol/l)</td><td char="&#177;" align="char">109.3&#160;&#177;&#160;30.3 (1,317)</td><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="&#177;" align="char"/><td char="." align="char"/><td align="left"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 1 (Gc1&#160;s)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">103.7&#160;&#177;&#160;29.1 (270)</td><td char="&#177;" align="char">109.8&#160;&#177;&#160;30.8 (648)</td><td char="&#177;" align="char">112.4&#160;&#177;&#160;29.9 (399)</td><td char="." align="char">&#8593; 0.3</td><td align="left">4&#160;&#215;&#160;10<sup>&#8722;4</sup>*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 2 (Gc2)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">113.0&#160;&#177;&#160;30.9 (668)</td><td char="&#177;" align="char">105.6&#160;&#177;&#160;29.2 (541)</td><td char="&#177;" align="char">105.7&#160;&#177;&#160;28.9 (108)</td><td char="." align="char">&#8595; 0.2</td><td align="left">5&#160;&#215;&#160;10<sup>&#8722;5</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Hap 3 (Gc1f)</td><td char="&#177;" align="char"/><td char="&#177;" align="char">108.9&#160;&#177;&#160;29.7 (922)</td><td char="&#177;" align="char">111.0&#160;&#177;&#160;31.5 (360)</td><td char="&#177;" align="char">102.0&#160;&#177;&#160;32.2 (35)</td><td char="." align="char">&#8595; 0.2</td><td align="left">0.18</td></tr></tbody></table><table-wrap-foot><p textid="34">Data are presented as mean&#160;&#177;&#160;SD (number of subjects). Vitamin D level was adjusted for age and gender</p><p textid="35"><sup>#</sup><italic>P</italic> value for trend (*&#160;estimated by linear regression analysis) and ANOVA</p></table-wrap-foot></table-wrap>
###xml 1041 1044 <span type="species:ncbi:9606">men</span>
###xml 1049 1054 <span type="species:ncbi:9606">women</span>
We measured serum vitamin D level in a subgroup (n = 1,317) of the Rotterdam Study. The vitamin D levels (mean and standard deviation [SD]) of serum 25(OH)D3 and 1,25(OH)2D3 in our study population were 65.5 +/- 27.3 nmol/l and 109.3 +/- 30.3 pmol/l, respectively (Table 1). Haplotype 1 (Gc1s) is significantly associated with 7.4 nmol/l (0.3 SD) increased serum level of 25(OH)D3 (P = 3 x 10-4 by a linear regression test for trend) and 8.4 +/- 0.3 pmol/l 1,25(OH)2D3 (P = 4 x 10-4 for trend). In contrast, haplotype 2 (Gc2) is significantly associated with a 15.7 +/- 0.6 nmol/l decreased serum level of 25(OH)D3 (P = 3 x 10-6) and 7.3 +/- 0.2 pmol/l 1,25(OH)2D3 (P = 5 x 10-5). The differences in serum vitamin D level between the noncarriers and carriers of haplotype alleles were from 0.2 to 0.6 SD. The associations were independent of age and gender. No significant difference in serum vitamin D level by haplotype3 (Gc1f) genotype was found.Table 1Serum vitamin D level by haplotypes of DBP (Gc) codon 416-420 in a subset of elderly men and women of the entire cohortMean +/- SD (total number)By haplotypes of DBP codon 416-420Noncarrier vs. homozygous (SD)P#NoncarrierHeterozygousHomozygous25-OH-D3 (nmol/l)65.5 +/- 27.3 (1312)    Hap 1 (Gc1 s)61.1 +/- 26.3 (269)65.4 +/- 26.9 (647)68.5 +/- 28.3 (396)upward arrow 0.33 x 10-4*    Hap 2 (Gc2)74.2 +/- 28.3 (665)63.0 +/- 25.6 (540)58.5 +/- 27.1 (107)downward arrow 0.63 x 10-6*    Hap 3 (Gc1f)65.0 +/- 27.2 (917)66.7 +/- 27.6 (360)64.9 +/- 27.1 (35)downward arrow 0.0040.571,25-(OH)2-D3 (pmol/l)109.3 +/- 30.3 (1,317)    Hap 1 (Gc1 s)103.7 +/- 29.1 (270)109.8 +/- 30.8 (648)112.4 +/- 29.9 (399)upward arrow 0.34 x 10-4*    Hap 2 (Gc2)113.0 +/- 30.9 (668)105.6 +/- 29.2 (541)105.7 +/- 28.9 (108)downward arrow 0.25 x 10-5    Hap 3 (Gc1f)108.9 +/- 29.7 (922)111.0 +/- 31.5 (360)102.0 +/- 32.2 (35)downward arrow 0.20.18Data are presented as mean +/- SD (number of subjects). Vitamin D level was adjusted for age and gender#P value for trend (* estimated by linear regression analysis) and ANOVA
###end p 32
###begin p 33
###xml 85 88 <span type="species:ncbi:9606">men</span>
###xml 93 98 <span type="species:ncbi:9606">women</span>
Serum vitamin D level by haplotypes of DBP (Gc) codon 416-420 in a subset of elderly men and women of the entire cohort
###end p 33
###begin p 34
Data are presented as mean +/- SD (number of subjects). Vitamin D level was adjusted for age and gender
###end p 34
###begin p 35
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
#P value for trend (* estimated by linear regression analysis) and ANOVA
###end p 35
###begin title 36
DBP Haplotypes and Fracture Risk
###end title 36
###begin p 37
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 299 300 299 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 459 466 459 466 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 466 550 466 550 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38">Risk of fracture by DBP haplotypes of DBP codon 416&#8211;420 in 6,181 elderly individuals</p>
###xml 466 550 466 550 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="38">Risk of fracture by DBP haplotypes of DBP codon 416&#8211;420 in 6,181 elderly individuals</p></caption>
###xml 550 550 550 550 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"/>
###xml 550 555 550 555 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Total</th>
###xml 555 586 555 586 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3">Haplotypes of DBP codon 416&#8211;420</th>
###xml 586 587 586 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 586 587 586 587 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"><italic>P</italic></th>
###xml 550 587 550 587 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2"/><th align="left" rowspan="2">Total</th><th align="left" colspan="3">Haplotypes of DBP codon 416&#8211;420</th><th align="left" rowspan="2"><italic>P</italic></th></tr>
###xml 587 597 587 597 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Noncarrier</th>
###xml 597 609 597 609 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Heterozygous</th>
###xml 609 619 609 619 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Homozygous</th>
###xml 587 619 587 619 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr>
###xml 550 619 550 619 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Total</th><th align="left" colspan="3">Haplotypes of DBP codon 416&#8211;420</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead>
###xml 619 638 619 638 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6">Haplotype 1 (Gc1&#160;s)</td>
###xml 619 638 619 638 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6">Haplotype 1 (Gc1&#160;s)</td></tr>
###xml 638 656 638 656 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Case/total (%)</td>
###xml 656 672 656 672 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">905/6,181 (14.6)</td>
###xml 672 688 672 688 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">155/1,183 (13.1)</td>
###xml 688 704 688 704 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">456/3,068 (14.9)</td>
###xml 704 720 704 720 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">294/1,930 (15.2)</td>
###xml 720 725 720 725 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.13*</td>
###xml 638 725 638 725 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="." align="char">905/6,181 (14.6)</td><td align="left">155/1,183 (13.1)</td><td align="left">456/3,068 (14.9)</td><td align="left">294/1,930 (15.2)</td><td char="." align="char">0.13*</td></tr>
###xml 725 746 725 746 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td>
###xml 746 746 746 746 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 746 747 746 747 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 747 763 747 763 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.16 (0.95&#8211;1.41)</td>
###xml 763 779 763 779 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.19 (0.97&#8211;1.41)</td>
###xml 779 784 779 784 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.13*</td>
###xml 725 784 725 784 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">1.16 (0.95&#8211;1.41)</td><td align="left">1.19 (0.97&#8211;1.41)</td><td char="." align="char">0.13*</td></tr>
###xml 808 809 808 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 784 809 784 809 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td>
###xml 809 809 809 809 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 809 810 809 810 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 810 826 810 826 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.13 (0.93&#8211;1.38)</td>
###xml 826 842 826 842 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.20 (0.97&#8211;1.49)</td>
###xml 842 847 842 847 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.13*</td>
###xml 784 847 784 847 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td><td align="left"/><td align="left">1</td><td align="left">1.13 (0.93&#8211;1.38)</td><td align="left">1.20 (0.97&#8211;1.49)</td><td char="." align="char">0.13*</td></tr>
###xml 847 847 847 847 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 847 847 847 847 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 847 847 847 847 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 847 866 847 866 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Haplotype 1 carrier</td>
###xml 866 866 866 866 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 847 866 847 866 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left"/><td align="left"/><td align="left"/><td align="left" colspan="2">Haplotype 1 carrier</td><td char="." align="char"/></tr>
###xml 866 880 866 880 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Case/total (%)</td>
###xml 880 880 880 880 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 880 896 880 896 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">155/1,183 (13.1)</td>
###xml 896 912 896 912 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">750/4,998 (15.0)</td>
###xml 912 916 912 916 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.10</td>
###xml 866 916 866 916 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Case/total (%)</td><td align="left"/><td align="left">155/1,183 (13.1)</td><td align="left" colspan="2">750/4,998 (15.0)</td><td char="." align="char">0.10</td></tr>
###xml 940 941 940 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 916 941 916 941 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td>
###xml 941 941 941 941 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 941 942 941 942 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 942 958 942 958 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">1.16 (0.96&#8211;1.40)</td>
###xml 958 962 958 962 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.13</td>
###xml 916 962 916 962 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td><td align="left"/><td align="left">1</td><td align="left" colspan="2">1.16 (0.96&#8211;1.40)</td><td char="." align="char">0.13</td></tr>
###xml 962 979 962 979 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6">Haplotype 2 (Gc2)</td>
###xml 962 979 962 979 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6">Haplotype 2 (Gc2)</td></tr>
###xml 979 997 979 997 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Case/total (%)</td>
###xml 997 997 997 997 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 997 1013 997 1013 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">482/3,221 (15.1)</td>
###xml 1013 1029 1013 1029 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">348/2,477 (14.0)</td>
###xml 1029 1042 1029 1042 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">72/483 (14.9)</td>
###xml 1042 1046 1042 1046 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.56</td>
###xml 979 1046 979 1046 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td align="left"/><td align="left">482/3,221 (15.1)</td><td align="left">348/2,477 (14.0)</td><td align="left">72/483 (14.9)</td><td char="." align="char">0.56</td></tr>
###xml 1046 1067 1046 1067 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td>
###xml 1067 1067 1067 1067 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1067 1068 1067 1068 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1068 1084 1068 1084 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.92 (0.80&#8211;1.07)</td>
###xml 1084 1100 1084 1100 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.99 (0.76&#8211;1.29)</td>
###xml 1100 1104 1100 1104 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.56</td>
###xml 1046 1104 1046 1104 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.92 (0.80&#8211;1.07)</td><td align="left">0.99 (0.76&#8211;1.29)</td><td char="." align="char">0.56</td></tr>
###xml 1104 1128 1104 1128 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td>
###xml 1128 1128 1128 1128 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1128 1129 1128 1129 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1129 1145 1129 1145 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.89 (0.77&#8211;1.04)</td>
###xml 1145 1161 1145 1161 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.95 (0.72&#8211;1.25)</td>
###xml 1161 1165 1161 1165 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.35</td>
###xml 1104 1165 1104 1165 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.89 (0.77&#8211;1.04)</td><td align="left">0.95 (0.72&#8211;1.25)</td><td char="." align="char">0.35</td></tr>
###xml 1165 1183 1165 1183 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Haplotype 3 (Gc1f)</td>
###xml 1183 1183 1183 1183 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1183 1183 1183 1183 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1183 1183 1183 1183 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1183 1183 1183 1183 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1183 1183 1183 1183 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1165 1183 1165 1183 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Haplotype 3 (Gc1f)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td char="." align="char"/></tr>
###xml 1183 1201 1183 1201 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Case/total (%)</td>
###xml 1201 1201 1201 1201 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1201 1217 1201 1217 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">649/4,348 (14.9)</td>
###xml 1217 1233 1217 1233 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">239/1,686 (14.2)</td>
###xml 1233 1246 1233 1246 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">17/147 (11.6)</td>
###xml 1246 1251 1246 1251 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.24*</td>
###xml 1183 1251 1183 1251 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td align="left"/><td align="left">649/4,348 (14.9)</td><td align="left">239/1,686 (14.2)</td><td align="left">17/147 (11.6)</td><td char="." align="char">0.24*</td></tr>
###xml 1251 1272 1251 1272 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td>
###xml 1272 1272 1272 1272 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1272 1273 1272 1273 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1273 1289 1273 1289 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.94 (0.80&#8211;1.10)</td>
###xml 1289 1305 1289 1305 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.74 (0.45&#8211;1.24)</td>
###xml 1305 1310 1305 1310 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.24*</td>
###xml 1251 1310 1251 1310 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.94 (0.80&#8211;1.10)</td><td align="left">0.74 (0.45&#8211;1.24)</td><td char="." align="char">0.24*</td></tr>
###xml 1310 1334 1310 1334 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td>
###xml 1334 1334 1334 1334 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 1334 1335 1334 1335 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1335 1351 1335 1351 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.95 (0.81&#8211;1.12)</td>
###xml 1351 1367 1351 1367 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.84 (0.50&#8211;1.42)</td>
###xml 1367 1372 1367 1372 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.42*</td>
###xml 1310 1372 1310 1372 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.95 (0.81&#8211;1.12)</td><td align="left">0.84 (0.50&#8211;1.42)</td><td char="." align="char">0.42*</td></tr>
###xml 619 1372 619 1372 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="6">Haplotype 1 (Gc1&#160;s)</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="." align="char">905/6,181 (14.6)</td><td align="left">155/1,183 (13.1)</td><td align="left">456/3,068 (14.9)</td><td align="left">294/1,930 (15.2)</td><td char="." align="char">0.13*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">1.16 (0.95&#8211;1.41)</td><td align="left">1.19 (0.97&#8211;1.41)</td><td char="." align="char">0.13*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td><td align="left"/><td align="left">1</td><td align="left">1.13 (0.93&#8211;1.38)</td><td align="left">1.20 (0.97&#8211;1.49)</td><td char="." align="char">0.13*</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left" colspan="2">Haplotype 1 carrier</td><td char="." align="char"/></tr><tr><td align="left">Case/total (%)</td><td align="left"/><td align="left">155/1,183 (13.1)</td><td align="left" colspan="2">750/4,998 (15.0)</td><td char="." align="char">0.10</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td><td align="left"/><td align="left">1</td><td align="left" colspan="2">1.16 (0.96&#8211;1.40)</td><td char="." align="char">0.13</td></tr><tr><td align="left" colspan="6">Haplotype 2 (Gc2)</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td align="left"/><td align="left">482/3,221 (15.1)</td><td align="left">348/2,477 (14.0)</td><td align="left">72/483 (14.9)</td><td char="." align="char">0.56</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.92 (0.80&#8211;1.07)</td><td align="left">0.99 (0.76&#8211;1.29)</td><td char="." align="char">0.56</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.89 (0.77&#8211;1.04)</td><td align="left">0.95 (0.72&#8211;1.25)</td><td char="." align="char">0.35</td></tr><tr><td align="left">Haplotype 3 (Gc1f)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td align="left"/><td align="left">649/4,348 (14.9)</td><td align="left">239/1,686 (14.2)</td><td align="left">17/147 (11.6)</td><td char="." align="char">0.24*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.94 (0.80&#8211;1.10)</td><td align="left">0.74 (0.45&#8211;1.24)</td><td char="." align="char">0.24*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.95 (0.81&#8211;1.12)</td><td align="left">0.84 (0.50&#8211;1.42)</td><td char="." align="char">0.42*</td></tr></tbody>
###xml 550 1372 550 1372 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Total</th><th align="left" colspan="3">Haplotypes of DBP codon 416&#8211;420</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead><tbody><tr><td align="left" colspan="6">Haplotype 1 (Gc1&#160;s)</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="." align="char">905/6,181 (14.6)</td><td align="left">155/1,183 (13.1)</td><td align="left">456/3,068 (14.9)</td><td align="left">294/1,930 (15.2)</td><td char="." align="char">0.13*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">1.16 (0.95&#8211;1.41)</td><td align="left">1.19 (0.97&#8211;1.41)</td><td char="." align="char">0.13*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td><td align="left"/><td align="left">1</td><td align="left">1.13 (0.93&#8211;1.38)</td><td align="left">1.20 (0.97&#8211;1.49)</td><td char="." align="char">0.13*</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left" colspan="2">Haplotype 1 carrier</td><td char="." align="char"/></tr><tr><td align="left">Case/total (%)</td><td align="left"/><td align="left">155/1,183 (13.1)</td><td align="left" colspan="2">750/4,998 (15.0)</td><td char="." align="char">0.10</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td><td align="left"/><td align="left">1</td><td align="left" colspan="2">1.16 (0.96&#8211;1.40)</td><td char="." align="char">0.13</td></tr><tr><td align="left" colspan="6">Haplotype 2 (Gc2)</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td align="left"/><td align="left">482/3,221 (15.1)</td><td align="left">348/2,477 (14.0)</td><td align="left">72/483 (14.9)</td><td char="." align="char">0.56</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.92 (0.80&#8211;1.07)</td><td align="left">0.99 (0.76&#8211;1.29)</td><td char="." align="char">0.56</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.89 (0.77&#8211;1.04)</td><td align="left">0.95 (0.72&#8211;1.25)</td><td char="." align="char">0.35</td></tr><tr><td align="left">Haplotype 3 (Gc1f)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td align="left"/><td align="left">649/4,348 (14.9)</td><td align="left">239/1,686 (14.2)</td><td align="left">17/147 (11.6)</td><td char="." align="char">0.24*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.94 (0.80&#8211;1.10)</td><td align="left">0.74 (0.45&#8211;1.24)</td><td char="." align="char">0.24*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.95 (0.81&#8211;1.12)</td><td align="left">0.84 (0.50&#8211;1.42)</td><td char="." align="char">0.42*</td></tr></tbody></table>
###xml 1372 1373 1372 1373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 1372 1407 1372 1407 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39"><sup>#</sup>HR was adjusted for age and gender</p>
###xml 1415 1416 1415 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1407 1462 1407 1462 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40">*&#160;Trend <italic>P</italic> value estimated by linear regression analysis</p>
###xml 1372 1462 1372 1462 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39"><sup>#</sup>HR was adjusted for age and gender</p><p textid="40">*&#160;Trend <italic>P</italic> value estimated by linear regression analysis</p></table-wrap-foot>
###xml 459 1462 459 1462 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="38">Risk of fracture by DBP haplotypes of DBP codon 416&#8211;420 in 6,181 elderly individuals</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Total</th><th align="left" colspan="3">Haplotypes of DBP codon 416&#8211;420</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead><tbody><tr><td align="left" colspan="6">Haplotype 1 (Gc1&#160;s)</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="." align="char">905/6,181 (14.6)</td><td align="left">155/1,183 (13.1)</td><td align="left">456/3,068 (14.9)</td><td align="left">294/1,930 (15.2)</td><td char="." align="char">0.13*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">1.16 (0.95&#8211;1.41)</td><td align="left">1.19 (0.97&#8211;1.41)</td><td char="." align="char">0.13*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td><td align="left"/><td align="left">1</td><td align="left">1.13 (0.93&#8211;1.38)</td><td align="left">1.20 (0.97&#8211;1.49)</td><td char="." align="char">0.13*</td></tr><tr><td align="left"/><td align="left"/><td align="left"/><td align="left" colspan="2">Haplotype 1 carrier</td><td char="." align="char"/></tr><tr><td align="left">Case/total (%)</td><td align="left"/><td align="left">155/1,183 (13.1)</td><td align="left" colspan="2">750/4,998 (15.0)</td><td char="." align="char">0.10</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>#</sup></td><td align="left"/><td align="left">1</td><td align="left" colspan="2">1.16 (0.96&#8211;1.40)</td><td char="." align="char">0.13</td></tr><tr><td align="left" colspan="6">Haplotype 2 (Gc2)</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td align="left"/><td align="left">482/3,221 (15.1)</td><td align="left">348/2,477 (14.0)</td><td align="left">72/483 (14.9)</td><td char="." align="char">0.56</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.92 (0.80&#8211;1.07)</td><td align="left">0.99 (0.76&#8211;1.29)</td><td char="." align="char">0.56</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.89 (0.77&#8211;1.04)</td><td align="left">0.95 (0.72&#8211;1.25)</td><td char="." align="char">0.35</td></tr><tr><td align="left">Haplotype 3 (Gc1f)</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td char="." align="char"/></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td align="left"/><td align="left">649/4,348 (14.9)</td><td align="left">239/1,686 (14.2)</td><td align="left">17/147 (11.6)</td><td char="." align="char">0.24*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.94 (0.80&#8211;1.10)</td><td align="left">0.74 (0.45&#8211;1.24)</td><td char="." align="char">0.24*</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td align="left"/><td align="left">1</td><td align="left">0.95 (0.81&#8211;1.12)</td><td align="left">0.84 (0.50&#8211;1.42)</td><td char="." align="char">0.42*</td></tr></tbody></table><table-wrap-foot><p textid="39"><sup>#</sup>HR was adjusted for age and gender</p><p textid="40">*&#160;Trend <italic>P</italic> value estimated by linear regression analysis</p></table-wrap-foot></table-wrap>
###xml 1462 1469 1462 1469 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 1469 1566 1469 1566 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41">Characteristics of the study population of 6,181 elderly men and women by DBP haplotype 1 (Gc1&#160;s)</p>
###xml 1469 1566 1469 1566 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41">Characteristics of the study population of 6,181 elderly men and women by DBP haplotype 1 (Gc1&#160;s)</p></caption>
###xml 1580 1581 1580 1581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1566 1581 1566 1581 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Characteristic<sup>a</sup></th>
###xml 1581 1593 1581 1593 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Total cohort</th>
###xml 1593 1625 1593 1625 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3">Haplotype 1 of DBP codon 416&#8211;420</th>
###xml 1625 1626 1625 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1625 1626 1625 1626 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"><italic>P</italic></th>
###xml 1566 1626 1566 1626 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">Characteristic<sup>a</sup></th><th align="left" rowspan="2">Total cohort</th><th align="left" colspan="3">Haplotype 1 of DBP codon 416&#8211;420</th><th align="left" rowspan="2"><italic>P</italic></th></tr>
###xml 1626 1636 1626 1636 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Noncarrier</th>
###xml 1636 1648 1636 1648 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Heterozygous</th>
###xml 1648 1658 1648 1658 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Homozygous</th>
###xml 1626 1658 1626 1658 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr>
###xml 1566 1658 1566 1658 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">Characteristic<sup>a</sup></th><th align="left" rowspan="2">Total cohort</th><th align="left" colspan="3">Haplotype 1 of DBP codon 416&#8211;420</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead>
###xml 1658 1685 1658 1685 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Number (% in entire cohort)</td>
###xml 1685 1690 1685 1690 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6,181</td>
###xml 1690 1702 1690 1702 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1,183 (19.1)</td>
###xml 1702 1714 1702 1714 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3,068 (49.6)</td>
###xml 1714 1726 1714 1726 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1,930 (31.2)</td>
###xml 1726 1726 1726 1726 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char"/>
###xml 1658 1726 1658 1726 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Number (% in entire cohort)</td><td align="left">6,181</td><td align="left">1,183 (19.1)</td><td align="left">3,068 (49.6)</td><td align="left">1,930 (31.2)</td><td char="." align="char"/></tr>
###xml 1726 1745 1726 1745 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Female (% of group)</td>
###xml 1745 1757 1745 1757 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3,689 (59.7)</td>
###xml 1757 1767 1757 1767 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">703 (59.4)</td>
###xml 1767 1779 1767 1779 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1,831 (59.7)</td>
###xml 1779 1791 1779 1791 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1,155 (59.8)</td>
###xml 1791 1795 1791 1795 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.97</td>
###xml 1726 1795 1726 1795 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Female (% of group)</td><td align="left">3,689 (59.7)</td><td align="left">703 (59.4)</td><td align="left">1,831 (59.7)</td><td align="left">1,155 (59.8)</td><td char="." align="char">0.97</td></tr>
###xml 1806 1807 1806 1807 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1795 1807 1795 1807 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Age (years)<sup>b</sup></td>
###xml 1807 1819 1807 1817 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">69.4&#160;&#177;&#160;9.1</td>
###xml 1819 1831 1817 1827 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">69.3&#160;&#177;&#160;9.1</td>
###xml 1831 1843 1827 1837 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">69.7&#160;&#177;&#160;9.3</td>
###xml 1843 1855 1837 1847 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">69.1&#160;&#177;&#160;8.9</td>
###xml 1855 1859 1847 1851 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.07</td>
###xml 1795 1859 1795 1851 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Age (years)<sup>b</sup></td><td align="left">69.4&#160;&#177;&#160;9.1</td><td align="left">69.3&#160;&#177;&#160;9.1</td><td align="left">69.7&#160;&#177;&#160;9.3</td><td align="left">69.1&#160;&#177;&#160;8.9</td><td char="." align="char">0.07</td></tr>
###xml 1870 1871 1862 1863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1859 1871 1851 1863 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Height (cm)<sup>b</sup></td>
###xml 1871 1884 1863 1874 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">166.8&#160;&#177;&#160;9.5</td>
###xml 1884 1897 1874 1885 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">166.7&#160;&#177;&#160;9.4</td>
###xml 1897 1910 1885 1896 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">166.6&#160;&#177;&#160;9.5</td>
###xml 1910 1923 1896 1907 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">167.0&#160;&#177;&#160;9.7</td>
###xml 1923 1927 1907 1911 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.11</td>
###xml 1859 1927 1851 1911 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Height (cm)<sup>b</sup></td><td align="left">166.8&#160;&#177;&#160;9.5</td><td align="left">166.7&#160;&#177;&#160;9.4</td><td align="left">166.6&#160;&#177;&#160;9.5</td><td align="left">167.0&#160;&#177;&#160;9.7</td><td char="." align="char">0.11</td></tr>
###xml 1938 1939 1922 1923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1927 1939 1911 1923 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Weight (kg)<sup>b</sup></td>
###xml 1939 1952 1923 1934 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">73.2&#160;&#177;&#160;12.0</td>
###xml 1952 1965 1934 1945 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">73.2&#160;&#177;&#160;12.3</td>
###xml 1965 1978 1945 1956 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">73.2&#160;&#177;&#160;12.3</td>
###xml 1978 1991 1956 1967 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">73.0&#160;&#177;&#160;11.5</td>
###xml 1991 1995 1967 1971 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.68</td>
###xml 1927 1995 1911 1971 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Weight (kg)<sup>b</sup></td><td align="left">73.2&#160;&#177;&#160;12.0</td><td align="left">73.2&#160;&#177;&#160;12.3</td><td align="left">73.2&#160;&#177;&#160;12.3</td><td align="left">73.0&#160;&#177;&#160;11.5</td><td char="." align="char">0.68</td></tr>
###xml 2020 2021 1996 1997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1995 2021 1971 1997 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Dietary Ca intake (g/day)<sup>b</sup></td>
###xml 2021 2034 1997 2008 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.13&#160;&#177;&#160;0.36</td>
###xml 2034 2047 2008 2019 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.13&#160;&#177;&#160;0.37</td>
###xml 2047 2060 2019 2030 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.13&#160;&#177;&#160;0.36</td>
###xml 2060 2073 2030 2041 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.12&#160;&#177;&#160;0.35</td>
###xml 2073 2077 2041 2045 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.36</td>
###xml 1995 2077 1971 2045 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Dietary Ca intake (g/day)<sup>b</sup></td><td align="left">1.13&#160;&#177;&#160;0.36</td><td align="left">1.13&#160;&#177;&#160;0.37</td><td align="left">1.13&#160;&#177;&#160;0.36</td><td align="left">1.12&#160;&#177;&#160;0.35</td><td char="." align="char">0.36</td></tr>
###xml 2099 2100 2067 2068 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2101 2102 2069 2070 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2077 2102 2045 2070 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Femoral neck BMD (g/cm<sup>2</sup>)<sup>b</sup></td>
###xml 2102 2115 2070 2081 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.84&#160;&#177;&#160;0.14</td>
###xml 2115 2128 2081 2092 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.84&#160;&#177;&#160;0.13</td>
###xml 2128 2141 2092 2103 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.84&#160;&#177;&#160;0.14</td>
###xml 2141 2154 2103 2114 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.84&#160;&#177;&#160;0.14</td>
###xml 2154 2158 2114 2118 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.90</td>
###xml 2077 2158 2045 2118 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Femoral neck BMD (g/cm<sup>2</sup>)<sup>b</sup></td><td align="left">0.84&#160;&#177;&#160;0.14</td><td align="left">0.84&#160;&#177;&#160;0.13</td><td align="left">0.84&#160;&#177;&#160;0.14</td><td align="left">0.84&#160;&#177;&#160;0.14</td><td char="." align="char">0.90</td></tr>
###xml 2180 2181 2140 2141 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 2182 2183 2142 2143 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2158 2183 2118 2143 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Lumbar spine BMD (g/cm<sup>2</sup>)<sup>b</sup></td>
###xml 2183 2196 2143 2154 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.09&#160;&#177;&#160;0.20</td>
###xml 2196 2209 2154 2165 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.10&#160;&#177;&#160;0.20</td>
###xml 2209 2222 2165 2176 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.09&#160;&#177;&#160;0.20</td>
###xml 2222 2235 2176 2187 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.09&#160;&#177;&#160;0.19</td>
###xml 2235 2239 2187 2191 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.82</td>
###xml 2158 2239 2118 2191 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Lumbar spine BMD (g/cm<sup>2</sup>)<sup>b</sup></td><td align="left">1.09&#160;&#177;&#160;0.20</td><td align="left">1.10&#160;&#177;&#160;0.20</td><td align="left">1.09&#160;&#177;&#160;0.20</td><td align="left">1.09&#160;&#177;&#160;0.19</td><td char="." align="char">0.82</td></tr>
###xml 1658 2239 1658 2191 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Number (% in entire cohort)</td><td align="left">6,181</td><td align="left">1,183 (19.1)</td><td align="left">3,068 (49.6)</td><td align="left">1,930 (31.2)</td><td char="." align="char"/></tr><tr><td align="left">Female (% of group)</td><td align="left">3,689 (59.7)</td><td align="left">703 (59.4)</td><td align="left">1,831 (59.7)</td><td align="left">1,155 (59.8)</td><td char="." align="char">0.97</td></tr><tr><td align="left">Age (years)<sup>b</sup></td><td align="left">69.4&#160;&#177;&#160;9.1</td><td align="left">69.3&#160;&#177;&#160;9.1</td><td align="left">69.7&#160;&#177;&#160;9.3</td><td align="left">69.1&#160;&#177;&#160;8.9</td><td char="." align="char">0.07</td></tr><tr><td align="left">Height (cm)<sup>b</sup></td><td align="left">166.8&#160;&#177;&#160;9.5</td><td align="left">166.7&#160;&#177;&#160;9.4</td><td align="left">166.6&#160;&#177;&#160;9.5</td><td align="left">167.0&#160;&#177;&#160;9.7</td><td char="." align="char">0.11</td></tr><tr><td align="left">Weight (kg)<sup>b</sup></td><td align="left">73.2&#160;&#177;&#160;12.0</td><td align="left">73.2&#160;&#177;&#160;12.3</td><td align="left">73.2&#160;&#177;&#160;12.3</td><td align="left">73.0&#160;&#177;&#160;11.5</td><td char="." align="char">0.68</td></tr><tr><td align="left">Dietary Ca intake (g/day)<sup>b</sup></td><td align="left">1.13&#160;&#177;&#160;0.36</td><td align="left">1.13&#160;&#177;&#160;0.37</td><td align="left">1.13&#160;&#177;&#160;0.36</td><td align="left">1.12&#160;&#177;&#160;0.35</td><td char="." align="char">0.36</td></tr><tr><td align="left">Femoral neck BMD (g/cm<sup>2</sup>)<sup>b</sup></td><td align="left">0.84&#160;&#177;&#160;0.14</td><td align="left">0.84&#160;&#177;&#160;0.13</td><td align="left">0.84&#160;&#177;&#160;0.14</td><td align="left">0.84&#160;&#177;&#160;0.14</td><td char="." align="char">0.90</td></tr><tr><td align="left">Lumbar spine BMD (g/cm<sup>2</sup>)<sup>b</sup></td><td align="left">1.09&#160;&#177;&#160;0.20</td><td align="left">1.10&#160;&#177;&#160;0.20</td><td align="left">1.09&#160;&#177;&#160;0.20</td><td align="left">1.09&#160;&#177;&#160;0.19</td><td char="." align="char">0.82</td></tr></tbody>
###xml 1566 2239 1566 2191 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristic<sup>a</sup></th><th align="left" rowspan="2">Total cohort</th><th align="left" colspan="3">Haplotype 1 of DBP codon 416&#8211;420</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead><tbody><tr><td align="left">Number (% in entire cohort)</td><td align="left">6,181</td><td align="left">1,183 (19.1)</td><td align="left">3,068 (49.6)</td><td align="left">1,930 (31.2)</td><td char="." align="char"/></tr><tr><td align="left">Female (% of group)</td><td align="left">3,689 (59.7)</td><td align="left">703 (59.4)</td><td align="left">1,831 (59.7)</td><td align="left">1,155 (59.8)</td><td char="." align="char">0.97</td></tr><tr><td align="left">Age (years)<sup>b</sup></td><td align="left">69.4&#160;&#177;&#160;9.1</td><td align="left">69.3&#160;&#177;&#160;9.1</td><td align="left">69.7&#160;&#177;&#160;9.3</td><td align="left">69.1&#160;&#177;&#160;8.9</td><td char="." align="char">0.07</td></tr><tr><td align="left">Height (cm)<sup>b</sup></td><td align="left">166.8&#160;&#177;&#160;9.5</td><td align="left">166.7&#160;&#177;&#160;9.4</td><td align="left">166.6&#160;&#177;&#160;9.5</td><td align="left">167.0&#160;&#177;&#160;9.7</td><td char="." align="char">0.11</td></tr><tr><td align="left">Weight (kg)<sup>b</sup></td><td align="left">73.2&#160;&#177;&#160;12.0</td><td align="left">73.2&#160;&#177;&#160;12.3</td><td align="left">73.2&#160;&#177;&#160;12.3</td><td align="left">73.0&#160;&#177;&#160;11.5</td><td char="." align="char">0.68</td></tr><tr><td align="left">Dietary Ca intake (g/day)<sup>b</sup></td><td align="left">1.13&#160;&#177;&#160;0.36</td><td align="left">1.13&#160;&#177;&#160;0.37</td><td align="left">1.13&#160;&#177;&#160;0.36</td><td align="left">1.12&#160;&#177;&#160;0.35</td><td char="." align="char">0.36</td></tr><tr><td align="left">Femoral neck BMD (g/cm<sup>2</sup>)<sup>b</sup></td><td align="left">0.84&#160;&#177;&#160;0.14</td><td align="left">0.84&#160;&#177;&#160;0.13</td><td align="left">0.84&#160;&#177;&#160;0.14</td><td align="left">0.84&#160;&#177;&#160;0.14</td><td char="." align="char">0.90</td></tr><tr><td align="left">Lumbar spine BMD (g/cm<sup>2</sup>)<sup>b</sup></td><td align="left">1.09&#160;&#177;&#160;0.20</td><td align="left">1.10&#160;&#177;&#160;0.20</td><td align="left">1.09&#160;&#177;&#160;0.20</td><td align="left">1.09&#160;&#177;&#160;0.19</td><td char="." align="char">0.82</td></tr></tbody></table>
###xml 2239 2240 2191 2192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2420 2421 2372 2373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2494 2495 2446 2447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2239 2548 2191 2500 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><sup>a</sup>The following adjustments were applied: age, adjusted for gender; height, adjusted for age and gender; weight, adjusted for age, gender, and body height; dietary Ca intake, subset <italic>n</italic>&#160;=&#160;4747 adjusted for age, gender, and dietary energy intake; BMD, subset <italic>n</italic>&#160;=&#160;5,027 adjusted for age, gender, height, and weight</p>
###xml 2548 2549 2500 2501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2548 2582 2500 2532 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43"><sup>b</sup>Data are presented as mean&#160;&#177;&#160;SD</p>
###xml 2239 2582 2191 2532 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42"><sup>a</sup>The following adjustments were applied: age, adjusted for gender; height, adjusted for age and gender; weight, adjusted for age, gender, and body height; dietary Ca intake, subset <italic>n</italic>&#160;=&#160;4747 adjusted for age, gender, and dietary energy intake; BMD, subset <italic>n</italic>&#160;=&#160;5,027 adjusted for age, gender, height, and weight</p><p textid="43"><sup>b</sup>Data are presented as mean&#160;&#177;&#160;SD</p></table-wrap-foot>
###xml 1462 2582 1462 2532 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="41">Characteristics of the study population of 6,181 elderly men and women by DBP haplotype 1 (Gc1&#160;s)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Characteristic<sup>a</sup></th><th align="left" rowspan="2">Total cohort</th><th align="left" colspan="3">Haplotype 1 of DBP codon 416&#8211;420</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead><tbody><tr><td align="left">Number (% in entire cohort)</td><td align="left">6,181</td><td align="left">1,183 (19.1)</td><td align="left">3,068 (49.6)</td><td align="left">1,930 (31.2)</td><td char="." align="char"/></tr><tr><td align="left">Female (% of group)</td><td align="left">3,689 (59.7)</td><td align="left">703 (59.4)</td><td align="left">1,831 (59.7)</td><td align="left">1,155 (59.8)</td><td char="." align="char">0.97</td></tr><tr><td align="left">Age (years)<sup>b</sup></td><td align="left">69.4&#160;&#177;&#160;9.1</td><td align="left">69.3&#160;&#177;&#160;9.1</td><td align="left">69.7&#160;&#177;&#160;9.3</td><td align="left">69.1&#160;&#177;&#160;8.9</td><td char="." align="char">0.07</td></tr><tr><td align="left">Height (cm)<sup>b</sup></td><td align="left">166.8&#160;&#177;&#160;9.5</td><td align="left">166.7&#160;&#177;&#160;9.4</td><td align="left">166.6&#160;&#177;&#160;9.5</td><td align="left">167.0&#160;&#177;&#160;9.7</td><td char="." align="char">0.11</td></tr><tr><td align="left">Weight (kg)<sup>b</sup></td><td align="left">73.2&#160;&#177;&#160;12.0</td><td align="left">73.2&#160;&#177;&#160;12.3</td><td align="left">73.2&#160;&#177;&#160;12.3</td><td align="left">73.0&#160;&#177;&#160;11.5</td><td char="." align="char">0.68</td></tr><tr><td align="left">Dietary Ca intake (g/day)<sup>b</sup></td><td align="left">1.13&#160;&#177;&#160;0.36</td><td align="left">1.13&#160;&#177;&#160;0.37</td><td align="left">1.13&#160;&#177;&#160;0.36</td><td align="left">1.12&#160;&#177;&#160;0.35</td><td char="." align="char">0.36</td></tr><tr><td align="left">Femoral neck BMD (g/cm<sup>2</sup>)<sup>b</sup></td><td align="left">0.84&#160;&#177;&#160;0.14</td><td align="left">0.84&#160;&#177;&#160;0.13</td><td align="left">0.84&#160;&#177;&#160;0.14</td><td align="left">0.84&#160;&#177;&#160;0.14</td><td char="." align="char">0.90</td></tr><tr><td align="left">Lumbar spine BMD (g/cm<sup>2</sup>)<sup>b</sup></td><td align="left">1.09&#160;&#177;&#160;0.20</td><td align="left">1.10&#160;&#177;&#160;0.20</td><td align="left">1.09&#160;&#177;&#160;0.20</td><td align="left">1.09&#160;&#177;&#160;0.19</td><td char="." align="char">0.82</td></tr></tbody></table><table-wrap-foot><p textid="42"><sup>a</sup>The following adjustments were applied: age, adjusted for gender; height, adjusted for age and gender; weight, adjusted for age, gender, and body height; dietary Ca intake, subset <italic>n</italic>&#160;=&#160;4747 adjusted for age, gender, and dietary energy intake; BMD, subset <italic>n</italic>&#160;=&#160;5,027 adjusted for age, gender, height, and weight</p><p textid="43"><sup>b</sup>Data are presented as mean&#160;&#177;&#160;SD</p></table-wrap-foot></table-wrap>
###xml 1526 1529 <span type="species:ncbi:9606">men</span>
###xml 1534 1539 <span type="species:ncbi:9606">women</span>
No significant difference of fracture incidence was observed by DBP haplotypes, although we found a small increasing trend of fracture risk by DBP haplotype 1 (P = 0.13 for dominant or additive genetic models, Table 2). The baseline characteristics by haplotype 1 of the DBP gene are shown in Table 3. In our study population, we did not observe a relationship between DBP haplotype 1 genotype and age, gender, body height, weight, clinical fracture, and BMD.Table 2Risk of fracture by DBP haplotypes of DBP codon 416-420 in 6,181 elderly individualsTotalHaplotypes of DBP codon 416-420PNoncarrierHeterozygousHomozygousHaplotype 1 (Gc1 s)    Case/total (%)905/6,181 (14.6)155/1,183 (13.1)456/3,068 (14.9)294/1,930 (15.2)0.13*    Crude HR (95% CI)11.16 (0.95-1.41)1.19 (0.97-1.41)0.13*    Adjusted HR (95% CI)#11.13 (0.93-1.38)1.20 (0.97-1.49)0.13*Haplotype 1 carrierCase/total (%)155/1,183 (13.1)750/4,998 (15.0)0.10    Adjusted HR (95% CI)#11.16 (0.96-1.40)0.13Haplotype 2 (Gc2)    Case/total (%)482/3,221 (15.1)348/2,477 (14.0)72/483 (14.9)0.56    Crude HR (95% CI)10.92 (0.80-1.07)0.99 (0.76-1.29)0.56    Adjusted HR (95% CI)10.89 (0.77-1.04)0.95 (0.72-1.25)0.35Haplotype 3 (Gc1f)    Case/total (%)649/4,348 (14.9)239/1,686 (14.2)17/147 (11.6)0.24*    Crude HR (95% CI)10.94 (0.80-1.10)0.74 (0.45-1.24)0.24*    Adjusted HR (95% CI)10.95 (0.81-1.12)0.84 (0.50-1.42)0.42*#HR was adjusted for age and gender* Trend P value estimated by linear regression analysisTable 3Characteristics of the study population of 6,181 elderly men and women by DBP haplotype 1 (Gc1 s)CharacteristicaTotal cohortHaplotype 1 of DBP codon 416-420PNoncarrierHeterozygousHomozygousNumber (% in entire cohort)6,1811,183 (19.1)3,068 (49.6)1,930 (31.2)Female (% of group)3,689 (59.7)703 (59.4)1,831 (59.7)1,155 (59.8)0.97Age (years)b69.4 +/- 9.169.3 +/- 9.169.7 +/- 9.369.1 +/- 8.90.07Height (cm)b166.8 +/- 9.5166.7 +/- 9.4166.6 +/- 9.5167.0 +/- 9.70.11Weight (kg)b73.2 +/- 12.073.2 +/- 12.373.2 +/- 12.373.0 +/- 11.50.68Dietary Ca intake (g/day)b1.13 +/- 0.361.13 +/- 0.371.13 +/- 0.361.12 +/- 0.350.36Femoral neck BMD (g/cm2)b0.84 +/- 0.140.84 +/- 0.130.84 +/- 0.140.84 +/- 0.140.90Lumbar spine BMD (g/cm2)b1.09 +/- 0.201.10 +/- 0.201.09 +/- 0.201.09 +/- 0.190.82aThe following adjustments were applied: age, adjusted for gender; height, adjusted for age and gender; weight, adjusted for age, gender, and body height; dietary Ca intake, subset n = 4747 adjusted for age, gender, and dietary energy intake; BMD, subset n = 5,027 adjusted for age, gender, height, and weightbData are presented as mean +/- SD
###end p 37
###begin p 38
Risk of fracture by DBP haplotypes of DBP codon 416-420 in 6,181 elderly individuals
###end p 38
###begin p 39
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
#HR was adjusted for age and gender
###end p 39
###begin p 40
###xml 8 9 8 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
* Trend P value estimated by linear regression analysis
###end p 40
###begin p 41
###xml 57 60 <span type="species:ncbi:9606">men</span>
###xml 65 70 <span type="species:ncbi:9606">women</span>
Characteristics of the study population of 6,181 elderly men and women by DBP haplotype 1 (Gc1 s)
###end p 41
###begin p 42
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 181 182 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 255 256 255 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
aThe following adjustments were applied: age, adjusted for gender; height, adjusted for age and gender; weight, adjusted for age, gender, and body height; dietary Ca intake, subset n = 4747 adjusted for age, gender, and dietary energy intake; BMD, subset n = 5,027 adjusted for age, gender, height, and weight
###end p 42
###begin p 43
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bData are presented as mean +/- SD
###end p 43
###begin title 44
Interaction Between DBP and VDR Genotypes for Osteoporosis
###end title 44
###begin p 45
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 331 332 331 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab4" ref-type="table">4</xref>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 807 808 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 966 973 966 973 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;4</label>
###xml 973 1077 973 1077 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46">Interaction between DBP haplotype 1 (Gc1s) and VDR block 5-haplotype 1 for the risk of clinical fracture</p>
###xml 973 1077 973 1077 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46">Interaction between DBP haplotype 1 (Gc1s) and VDR block 5-haplotype 1 for the risk of clinical fracture</p></caption>
###xml 1077 1077 1077 1077 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"/>
###xml 1077 1082 1077 1082 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Total</th>
###xml 1082 1117 1082 1117 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="3">Genotype of VDR block 5-haplotype 1</th>
###xml 1117 1118 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1117 1118 1117 1118 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2"><italic>P</italic></th>
###xml 1077 1118 1077 1118 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2"/><th align="left" rowspan="2">Total</th><th align="left" colspan="3">Genotype of VDR block 5-haplotype 1</th><th align="left" rowspan="2"><italic>P</italic></th></tr>
###xml 1118 1128 1118 1128 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Noncarrier</th>
###xml 1128 1140 1128 1140 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Heterozygous</th>
###xml 1140 1150 1140 1150 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Homozygous</th>
###xml 1118 1150 1118 1150 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr>
###xml 1077 1150 1077 1150 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Total</th><th align="left" colspan="3">Genotype of VDR block 5-haplotype 1</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead>
###xml 1150 1172 1150 1172 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6">Total study population</td>
###xml 1150 1172 1150 1172 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6">Total study population</td></tr>
###xml 1172 1190 1172 1190 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Case/total (%)</td>
###xml 1190 1206 1190 1206 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">881/6,009 (14.7)</td>
###xml 1206 1222 1206 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">255/1,930 (13.2)</td>
###xml 1222 1238 1222 1238 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">428/2,887 (14.8)</td>
###xml 1238 1254 1238 1254 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">198/1,192 (16.6)</td>
###xml 1254 1259 1254 1259 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.009</td>
###xml 1172 1259 1172 1259 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">881/6,009 (14.7)</td><td align="left">255/1,930 (13.2)</td><td align="left">428/2,887 (14.8)</td><td align="left">198/1,192 (16.6)</td><td char="." align="char">0.009</td></tr>
###xml 1259 1280 1259 1280 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td>
###xml 1280 1280 1280 1280 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1280 1281 1280 1281 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1281 1297 1281 1297 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.14 (0.98&#8211;1.33)</td>
###xml 1297 1313 1297 1313 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.29 (1.07&#8211;1.55)</td>
###xml 1318 1319 1318 1319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1313 1319 1313 1319 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.007<sup>c</sup></td>
###xml 1259 1319 1259 1319 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.14 (0.98&#8211;1.33)</td><td align="left">1.29 (1.07&#8211;1.55)</td><td char="." align="char">0.007<sup>c</sup></td></tr>
###xml 1343 1344 1343 1344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1319 1344 1319 1344 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>a</sup></td>
###xml 1344 1344 1344 1344 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1344 1345 1344 1345 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1345 1361 1345 1361 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.11 (0.95&#8211;1.30)</td>
###xml 1361 1377 1361 1377 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.27 (1.06&#8211;1.53)</td>
###xml 1381 1382 1381 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1377 1382 1377 1382 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.01<sup>c</sup></td>
###xml 1319 1382 1319 1382 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>a</sup></td><td char="(" align="char"/><td align="left">1</td><td align="left">1.11 (0.95&#8211;1.30)</td><td align="left">1.27 (1.06&#8211;1.53)</td><td char="." align="char">0.01<sup>c</sup></td></tr>
###xml 1382 1397 1382 1397 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6">By DBP genotype</td>
###xml 1382 1397 1382 1397 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6">By DBP genotype</td></tr>
###xml 1397 1421 1397 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Carrier of DBP haplotype</italic>
###xml 1421 1422 1421 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 1397 1422 1397 1422 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Carrier of DBP haplotype</italic><italic>1</italic></td>
###xml 1397 1422 1397 1422 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Carrier of DBP haplotype</italic><italic>1</italic></td></tr>
###xml 1422 1436 1422 1436 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Case/total (%)</td>
###xml 1436 1452 1436 1452 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">728/4,851 (15.0)</td>
###xml 1452 1468 1452 1468 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">209/1,564 (13.4)</td>
###xml 1468 1484 1468 1484 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">351/2,321 (15.1)</td>
###xml 1484 1498 1484 1498 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">168/966 (17.4)</td>
###xml 1498 1503 1498 1503 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.006</td>
###xml 1422 1503 1422 1503 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Case/total (%)</td><td char="(" align="char">728/4,851 (15.0)</td><td align="left">209/1,564 (13.4)</td><td align="left">351/2,321 (15.1)</td><td align="left">168/966 (17.4)</td><td char="." align="char">0.006</td></tr>
###xml 1503 1520 1503 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Crude HR (95% CI)</td>
###xml 1520 1520 1520 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1520 1521 1520 1521 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1521 1537 1521 1537 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.16 (0.98&#8211;1.38)</td>
###xml 1537 1553 1537 1553 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.33 (1.09&#8211;1.63)</td>
###xml 1558 1559 1558 1559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1553 1559 1553 1559 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.005<sup>c</sup></td>
###xml 1503 1559 1503 1559 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.16 (0.98&#8211;1.38)</td><td align="left">1.33 (1.09&#8211;1.63)</td><td char="." align="char">0.005<sup>c</sup></td></tr>
###xml 1559 1579 1559 1579 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Adjusted HR (95% CI)</td>
###xml 1579 1579 1579 1579 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1579 1580 1579 1580 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1580 1596 1580 1596 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.14 (0.96&#8211;1.35)</td>
###xml 1596 1612 1596 1612 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.32 (1.07&#8211;1.61)</td>
###xml 1617 1618 1617 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1612 1618 1612 1618 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.008<sup>c</sup></td>
###xml 1559 1618 1559 1618 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.14 (0.96&#8211;1.35)</td><td align="left">1.32 (1.07&#8211;1.61)</td><td char="." align="char">0.008<sup>c</sup></td></tr>
###xml 1618 1628 1618 1628 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6">Homozygous</td>
###xml 1618 1628 1618 1628 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6">Homozygous</td></tr>
###xml 1628 1646 1628 1646 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Case/total (%)</td>
###xml 1646 1661 1646 1661 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">281/1592 (15.0)</td>
###xml 1661 1674 1661 1674 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">82/529 (13.4)</td>
###xml 1674 1688 1674 1688 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">137/761 (15.3)</td>
###xml 1688 1701 1688 1701 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">62/302 (17.0)</td>
###xml 1701 1705 1701 1705 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.12</td>
###xml 1628 1705 1628 1705 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">281/1592 (15.0)</td><td align="left">82/529 (13.4)</td><td align="left">137/761 (15.3)</td><td align="left">62/302 (17.0)</td><td char="." align="char">0.12</td></tr>
###xml 1705 1726 1705 1726 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td>
###xml 1726 1726 1726 1726 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1726 1727 1726 1727 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1727 1743 1727 1743 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.15 (0.87&#8211;1.51)</td>
###xml 1743 1759 1743 1759 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.29 (0.93&#8211;1.80)</td>
###xml 1763 1764 1763 1764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1759 1764 1759 1764 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.13<sup>c</sup></td>
###xml 1705 1764 1705 1764 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.15 (0.87&#8211;1.51)</td><td align="left">1.29 (0.93&#8211;1.80)</td><td char="." align="char">0.13<sup>c</sup></td></tr>
###xml 1764 1788 1764 1788 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td>
###xml 1788 1788 1788 1788 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1788 1789 1788 1789 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1789 1805 1789 1805 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.12 (0.81&#8211;1.56)</td>
###xml 1805 1821 1805 1821 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.25 (0.81&#8211;1.56)</td>
###xml 1825 1826 1825 1826 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1821 1826 1821 1826 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.26<sup>c</sup></td>
###xml 1764 1826 1764 1826 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.12 (0.81&#8211;1.56)</td><td align="left">1.25 (0.81&#8211;1.56)</td><td char="." align="char">0.26<sup>c</sup></td></tr>
###xml 1826 1838 1826 1838 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6">Heterozygous</td>
###xml 1826 1838 1826 1838 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6">Heterozygous</td></tr>
###xml 1838 1856 1838 1856 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Case/total (%)</td>
###xml 1856 1871 1856 1871 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">447/2531 (15.0)</td>
###xml 1871 1885 1871 1885 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">127/826 (13.3)</td>
###xml 1885 1900 1885 1900 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">214/1209 (15.0)</td>
###xml 1900 1914 1900 1914 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">106/496 (17.6)</td>
###xml 1914 1918 1914 1918 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02</td>
###xml 1838 1918 1838 1918 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">447/2531 (15.0)</td><td align="left">127/826 (13.3)</td><td align="left">214/1209 (15.0)</td><td align="left">106/496 (17.6)</td><td char="." align="char">0.02</td></tr>
###xml 1918 1939 1918 1939 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td>
###xml 1939 1939 1939 1939 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 1939 1940 1939 1940 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 1940 1956 1940 1956 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.17 (0.94&#8211;1.46)</td>
###xml 1956 1972 1956 1972 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.36 (1.05&#8211;1.76)</td>
###xml 1976 1977 1976 1977 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1972 1977 1972 1977 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.02<sup>c</sup></td>
###xml 1918 1977 1918 1977 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.17 (0.94&#8211;1.46)</td><td align="left">1.36 (1.05&#8211;1.76)</td><td char="." align="char">0.02<sup>c</sup></td></tr>
###xml 1977 2001 1977 2001 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td>
###xml 2001 2001 2001 2001 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2001 2002 2001 2002 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 2002 2018 2002 2018 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.17 (0.92&#8211;1.50)</td>
###xml 2018 2034 2018 2034 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.20 (0.89&#8211;1.62)</td>
###xml 2038 2039 2038 2039 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 2034 2039 2034 2039 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.24<sup>c</sup></td>
###xml 1977 2039 1977 2039 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.17 (0.92&#8211;1.50)</td><td align="left">1.20 (0.89&#8211;1.62)</td><td char="." align="char">0.24<sup>c</sup></td></tr>
###xml 2039 2068 2039 2068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Noncarrier of DBP haplotype 1</italic>
###xml 2039 2068 2039 2068 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="6"><italic>Noncarrier of DBP haplotype 1</italic></td>
###xml 2039 2068 2039 2068 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="6"><italic>Noncarrier of DBP haplotype 1</italic></td></tr>
###xml 2068 2082 2068 2082 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Case/total (%)</td>
###xml 2082 2097 2082 2097 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">153/1158 (13.2)</td>
###xml 2097 2110 2097 2110 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">46/366 (12.6)</td>
###xml 2110 2123 2110 2123 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">77/566 (13.6)</td>
###xml 2123 2136 2123 2136 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">30/226 (13.3)</td>
###xml 2136 2140 2136 2140 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.90</td>
###xml 2068 2140 2068 2140 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Case/total (%)</td><td char="(" align="char">153/1158 (13.2)</td><td align="left">46/366 (12.6)</td><td align="left">77/566 (13.6)</td><td align="left">30/226 (13.3)</td><td char="." align="char">0.90</td></tr>
###xml 2140 2157 2140 2157 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Crude HR (95% CI)</td>
###xml 2157 2157 2157 2157 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2157 2158 2157 2158 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 2158 2174 2158 2174 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.06 (0.74&#8211;1.53)</td>
###xml 2174 2190 2174 2190 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.09 (0.69&#8211;1.72)</td>
###xml 2194 2195 2194 2195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 2190 2195 2190 2195 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.70<sup>c</sup></td>
###xml 2140 2195 2140 2195 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.06 (0.74&#8211;1.53)</td><td align="left">1.09 (0.69&#8211;1.72)</td><td char="." align="char">0.70<sup>c</sup></td></tr>
###xml 2215 2216 2215 2216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2195 2216 2195 2216 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Adjusted HR (95% CI)<sup>b</sup></td>
###xml 2216 2216 2216 2216 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char"/>
###xml 2216 2217 2216 2217 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1</td>
###xml 2217 2233 2217 2233 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0.93 (0.61&#8211;1.43)</td>
###xml 2233 2249 2233 2249 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1.12 (0.67&#8211;1.89)</td>
###xml 2253 2254 2253 2254 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 2249 2254 2249 2254 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="." align="char">0.73<sup>c</sup></td>
###xml 2195 2254 2195 2254 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Adjusted HR (95% CI)<sup>b</sup></td><td char="(" align="char"/><td align="left">1</td><td align="left">0.93 (0.61&#8211;1.43)</td><td align="left">1.12 (0.67&#8211;1.89)</td><td char="." align="char">0.73<sup>c</sup></td></tr>
###xml 1150 2254 1150 2254 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="6">Total study population</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">881/6,009 (14.7)</td><td align="left">255/1,930 (13.2)</td><td align="left">428/2,887 (14.8)</td><td align="left">198/1,192 (16.6)</td><td char="." align="char">0.009</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.14 (0.98&#8211;1.33)</td><td align="left">1.29 (1.07&#8211;1.55)</td><td char="." align="char">0.007<sup>c</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>a</sup></td><td char="(" align="char"/><td align="left">1</td><td align="left">1.11 (0.95&#8211;1.30)</td><td align="left">1.27 (1.06&#8211;1.53)</td><td char="." align="char">0.01<sup>c</sup></td></tr><tr><td align="left" colspan="6">By DBP genotype</td></tr><tr><td align="left" colspan="6"><italic>Carrier of DBP haplotype</italic><italic>1</italic></td></tr><tr><td align="left">Case/total (%)</td><td char="(" align="char">728/4,851 (15.0)</td><td align="left">209/1,564 (13.4)</td><td align="left">351/2,321 (15.1)</td><td align="left">168/966 (17.4)</td><td char="." align="char">0.006</td></tr><tr><td align="left">Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.16 (0.98&#8211;1.38)</td><td align="left">1.33 (1.09&#8211;1.63)</td><td char="." align="char">0.005<sup>c</sup></td></tr><tr><td align="left">Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.14 (0.96&#8211;1.35)</td><td align="left">1.32 (1.07&#8211;1.61)</td><td char="." align="char">0.008<sup>c</sup></td></tr><tr><td align="left" colspan="6">Homozygous</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">281/1592 (15.0)</td><td align="left">82/529 (13.4)</td><td align="left">137/761 (15.3)</td><td align="left">62/302 (17.0)</td><td char="." align="char">0.12</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.15 (0.87&#8211;1.51)</td><td align="left">1.29 (0.93&#8211;1.80)</td><td char="." align="char">0.13<sup>c</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.12 (0.81&#8211;1.56)</td><td align="left">1.25 (0.81&#8211;1.56)</td><td char="." align="char">0.26<sup>c</sup></td></tr><tr><td align="left" colspan="6">Heterozygous</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">447/2531 (15.0)</td><td align="left">127/826 (13.3)</td><td align="left">214/1209 (15.0)</td><td align="left">106/496 (17.6)</td><td char="." align="char">0.02</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.17 (0.94&#8211;1.46)</td><td align="left">1.36 (1.05&#8211;1.76)</td><td char="." align="char">0.02<sup>c</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.17 (0.92&#8211;1.50)</td><td align="left">1.20 (0.89&#8211;1.62)</td><td char="." align="char">0.24<sup>c</sup></td></tr><tr><td align="left" colspan="6"><italic>Noncarrier of DBP haplotype 1</italic></td></tr><tr><td align="left">Case/total (%)</td><td char="(" align="char">153/1158 (13.2)</td><td align="left">46/366 (12.6)</td><td align="left">77/566 (13.6)</td><td align="left">30/226 (13.3)</td><td char="." align="char">0.90</td></tr><tr><td align="left">Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.06 (0.74&#8211;1.53)</td><td align="left">1.09 (0.69&#8211;1.72)</td><td char="." align="char">0.70<sup>c</sup></td></tr><tr><td align="left">Adjusted HR (95% CI)<sup>b</sup></td><td char="(" align="char"/><td align="left">1</td><td align="left">0.93 (0.61&#8211;1.43)</td><td align="left">1.12 (0.67&#8211;1.89)</td><td char="." align="char">0.73<sup>c</sup></td></tr></tbody>
###xml 1077 2254 1077 2254 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Total</th><th align="left" colspan="3">Genotype of VDR block 5-haplotype 1</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead><tbody><tr><td align="left" colspan="6">Total study population</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">881/6,009 (14.7)</td><td align="left">255/1,930 (13.2)</td><td align="left">428/2,887 (14.8)</td><td align="left">198/1,192 (16.6)</td><td char="." align="char">0.009</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.14 (0.98&#8211;1.33)</td><td align="left">1.29 (1.07&#8211;1.55)</td><td char="." align="char">0.007<sup>c</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>a</sup></td><td char="(" align="char"/><td align="left">1</td><td align="left">1.11 (0.95&#8211;1.30)</td><td align="left">1.27 (1.06&#8211;1.53)</td><td char="." align="char">0.01<sup>c</sup></td></tr><tr><td align="left" colspan="6">By DBP genotype</td></tr><tr><td align="left" colspan="6"><italic>Carrier of DBP haplotype</italic><italic>1</italic></td></tr><tr><td align="left">Case/total (%)</td><td char="(" align="char">728/4,851 (15.0)</td><td align="left">209/1,564 (13.4)</td><td align="left">351/2,321 (15.1)</td><td align="left">168/966 (17.4)</td><td char="." align="char">0.006</td></tr><tr><td align="left">Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.16 (0.98&#8211;1.38)</td><td align="left">1.33 (1.09&#8211;1.63)</td><td char="." align="char">0.005<sup>c</sup></td></tr><tr><td align="left">Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.14 (0.96&#8211;1.35)</td><td align="left">1.32 (1.07&#8211;1.61)</td><td char="." align="char">0.008<sup>c</sup></td></tr><tr><td align="left" colspan="6">Homozygous</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">281/1592 (15.0)</td><td align="left">82/529 (13.4)</td><td align="left">137/761 (15.3)</td><td align="left">62/302 (17.0)</td><td char="." align="char">0.12</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.15 (0.87&#8211;1.51)</td><td align="left">1.29 (0.93&#8211;1.80)</td><td char="." align="char">0.13<sup>c</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.12 (0.81&#8211;1.56)</td><td align="left">1.25 (0.81&#8211;1.56)</td><td char="." align="char">0.26<sup>c</sup></td></tr><tr><td align="left" colspan="6">Heterozygous</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">447/2531 (15.0)</td><td align="left">127/826 (13.3)</td><td align="left">214/1209 (15.0)</td><td align="left">106/496 (17.6)</td><td char="." align="char">0.02</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.17 (0.94&#8211;1.46)</td><td align="left">1.36 (1.05&#8211;1.76)</td><td char="." align="char">0.02<sup>c</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.17 (0.92&#8211;1.50)</td><td align="left">1.20 (0.89&#8211;1.62)</td><td char="." align="char">0.24<sup>c</sup></td></tr><tr><td align="left" colspan="6"><italic>Noncarrier of DBP haplotype 1</italic></td></tr><tr><td align="left">Case/total (%)</td><td char="(" align="char">153/1158 (13.2)</td><td align="left">46/366 (12.6)</td><td align="left">77/566 (13.6)</td><td align="left">30/226 (13.3)</td><td char="." align="char">0.90</td></tr><tr><td align="left">Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.06 (0.74&#8211;1.53)</td><td align="left">1.09 (0.69&#8211;1.72)</td><td char="." align="char">0.70<sup>c</sup></td></tr><tr><td align="left">Adjusted HR (95% CI)<sup>b</sup></td><td char="(" align="char"/><td align="left">1</td><td align="left">0.93 (0.61&#8211;1.43)</td><td align="left">1.12 (0.67&#8211;1.89)</td><td char="." align="char">0.73<sup>c</sup></td></tr></tbody></table>
###xml 2254 2255 2254 2255 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2254 2294 2254 2294 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="47"><sup>a</sup>Subjects with DBP and VDR genotype data</p>
###xml 2294 2295 2294 2295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2294 2382 2294 2382 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48"><sup>b</sup>HR was adjusted for age, gender, femeral neck and spine BMD, as well as BMI at baseline</p>
###xml 2382 2383 2382 2383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 2389 2390 2389 2390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 2382 2437 2382 2437 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="49"><sup>c</sup>Trend <italic>P</italic> value was estimated by Cox regression analysis</p>
###xml 2254 2437 2254 2437 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="47"><sup>a</sup>Subjects with DBP and VDR genotype data</p><p textid="48"><sup>b</sup>HR was adjusted for age, gender, femeral neck and spine BMD, as well as BMI at baseline</p><p textid="49"><sup>c</sup>Trend <italic>P</italic> value was estimated by Cox regression analysis</p></table-wrap-foot>
###xml 966 2437 966 2437 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab4"><label>Table&#160;4</label><caption><p textid="46">Interaction between DBP haplotype 1 (Gc1s) and VDR block 5-haplotype 1 for the risk of clinical fracture</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" rowspan="2">Total</th><th align="left" colspan="3">Genotype of VDR block 5-haplotype 1</th><th align="left" rowspan="2"><italic>P</italic></th></tr><tr><th align="left">Noncarrier</th><th align="left">Heterozygous</th><th align="left">Homozygous</th></tr></thead><tbody><tr><td align="left" colspan="6">Total study population</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">881/6,009 (14.7)</td><td align="left">255/1,930 (13.2)</td><td align="left">428/2,887 (14.8)</td><td align="left">198/1,192 (16.6)</td><td char="." align="char">0.009</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.14 (0.98&#8211;1.33)</td><td align="left">1.29 (1.07&#8211;1.55)</td><td char="." align="char">0.007<sup>c</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)<sup>a</sup></td><td char="(" align="char"/><td align="left">1</td><td align="left">1.11 (0.95&#8211;1.30)</td><td align="left">1.27 (1.06&#8211;1.53)</td><td char="." align="char">0.01<sup>c</sup></td></tr><tr><td align="left" colspan="6">By DBP genotype</td></tr><tr><td align="left" colspan="6"><italic>Carrier of DBP haplotype</italic><italic>1</italic></td></tr><tr><td align="left">Case/total (%)</td><td char="(" align="char">728/4,851 (15.0)</td><td align="left">209/1,564 (13.4)</td><td align="left">351/2,321 (15.1)</td><td align="left">168/966 (17.4)</td><td char="." align="char">0.006</td></tr><tr><td align="left">Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.16 (0.98&#8211;1.38)</td><td align="left">1.33 (1.09&#8211;1.63)</td><td char="." align="char">0.005<sup>c</sup></td></tr><tr><td align="left">Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.14 (0.96&#8211;1.35)</td><td align="left">1.32 (1.07&#8211;1.61)</td><td char="." align="char">0.008<sup>c</sup></td></tr><tr><td align="left" colspan="6">Homozygous</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">281/1592 (15.0)</td><td align="left">82/529 (13.4)</td><td align="left">137/761 (15.3)</td><td align="left">62/302 (17.0)</td><td char="." align="char">0.12</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.15 (0.87&#8211;1.51)</td><td align="left">1.29 (0.93&#8211;1.80)</td><td char="." align="char">0.13<sup>c</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.12 (0.81&#8211;1.56)</td><td align="left">1.25 (0.81&#8211;1.56)</td><td char="." align="char">0.26<sup>c</sup></td></tr><tr><td align="left" colspan="6">Heterozygous</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Case/total (%)</td><td char="(" align="char">447/2531 (15.0)</td><td align="left">127/826 (13.3)</td><td align="left">214/1209 (15.0)</td><td align="left">106/496 (17.6)</td><td char="." align="char">0.02</td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.17 (0.94&#8211;1.46)</td><td align="left">1.36 (1.05&#8211;1.76)</td><td char="." align="char">0.02<sup>c</sup></td></tr><tr><td align="left">&#160;&#160;&#160;&#160;Adjusted HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.17 (0.92&#8211;1.50)</td><td align="left">1.20 (0.89&#8211;1.62)</td><td char="." align="char">0.24<sup>c</sup></td></tr><tr><td align="left" colspan="6"><italic>Noncarrier of DBP haplotype 1</italic></td></tr><tr><td align="left">Case/total (%)</td><td char="(" align="char">153/1158 (13.2)</td><td align="left">46/366 (12.6)</td><td align="left">77/566 (13.6)</td><td align="left">30/226 (13.3)</td><td char="." align="char">0.90</td></tr><tr><td align="left">Crude HR (95% CI)</td><td char="(" align="char"/><td align="left">1</td><td align="left">1.06 (0.74&#8211;1.53)</td><td align="left">1.09 (0.69&#8211;1.72)</td><td char="." align="char">0.70<sup>c</sup></td></tr><tr><td align="left">Adjusted HR (95% CI)<sup>b</sup></td><td char="(" align="char"/><td align="left">1</td><td align="left">0.93 (0.61&#8211;1.43)</td><td align="left">1.12 (0.67&#8211;1.89)</td><td char="." align="char">0.73<sup>c</sup></td></tr></tbody></table><table-wrap-foot><p textid="47"><sup>a</sup>Subjects with DBP and VDR genotype data</p><p textid="48"><sup>b</sup>HR was adjusted for age, gender, femeral neck and spine BMD, as well as BMI at baseline</p><p textid="49"><sup>c</sup>Trend <italic>P</italic> value was estimated by Cox regression analysis</p></table-wrap-foot></table-wrap>
We investigated the interaction between DBP and VDR gene variants on the risk of osteoporosis in a regression model for fracture. The interaction P value between the DBP and VDR genotypes in the relation to fracture risk was 0.015. We therefore stratified the study population as noncarriers and carriers of DBP haplotype 1 (Table 4). In the group of DBP haplotype 1 carriers, the genetic effect of the VDR block 5-haplotype 1 on fracture risk remained and subjects homozygous for VDR block 5-haplotype 1 had a 32% increased fracture risk compared to noncarriers of this allele (P = 0.008 by the Cox model). This association was independent of age and gender. However, in subjects not carrying the DBP haplotype 1 allele, we did not observe an association between VDR block 5-haplotype 1 and fracture risk (P = 0.70). We did not achieve sufficient statistical power for analysis of this genetic interaction in the low and high calcium intake groups (data not shown).Table 4Interaction between DBP haplotype 1 (Gc1s) and VDR block 5-haplotype 1 for the risk of clinical fractureTotalGenotype of VDR block 5-haplotype 1PNoncarrierHeterozygousHomozygousTotal study population    Case/total (%)881/6,009 (14.7)255/1,930 (13.2)428/2,887 (14.8)198/1,192 (16.6)0.009    Crude HR (95% CI)11.14 (0.98-1.33)1.29 (1.07-1.55)0.007c    Adjusted HR (95% CI)a11.11 (0.95-1.30)1.27 (1.06-1.53)0.01cBy DBP genotypeCarrier of DBP haplotype1Case/total (%)728/4,851 (15.0)209/1,564 (13.4)351/2,321 (15.1)168/966 (17.4)0.006Crude HR (95% CI)11.16 (0.98-1.38)1.33 (1.09-1.63)0.005cAdjusted HR (95% CI)11.14 (0.96-1.35)1.32 (1.07-1.61)0.008cHomozygous    Case/total (%)281/1592 (15.0)82/529 (13.4)137/761 (15.3)62/302 (17.0)0.12    Crude HR (95% CI)11.15 (0.87-1.51)1.29 (0.93-1.80)0.13c    Adjusted HR (95% CI)11.12 (0.81-1.56)1.25 (0.81-1.56)0.26cHeterozygous    Case/total (%)447/2531 (15.0)127/826 (13.3)214/1209 (15.0)106/496 (17.6)0.02    Crude HR (95% CI)11.17 (0.94-1.46)1.36 (1.05-1.76)0.02c    Adjusted HR (95% CI)11.17 (0.92-1.50)1.20 (0.89-1.62)0.24cNoncarrier of DBP haplotype 1Case/total (%)153/1158 (13.2)46/366 (12.6)77/566 (13.6)30/226 (13.3)0.90Crude HR (95% CI)11.06 (0.74-1.53)1.09 (0.69-1.72)0.70cAdjusted HR (95% CI)b10.93 (0.61-1.43)1.12 (0.67-1.89)0.73caSubjects with DBP and VDR genotype databHR was adjusted for age, gender, femeral neck and spine BMD, as well as BMI at baselinecTrend P value was estimated by Cox regression analysis
###end p 45
###begin p 46
Interaction between DBP haplotype 1 (Gc1s) and VDR block 5-haplotype 1 for the risk of clinical fracture
###end p 46
###begin p 47
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
aSubjects with DBP and VDR genotype data
###end p 47
###begin p 48
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
bHR was adjusted for age, gender, femeral neck and spine BMD, as well as BMI at baseline
###end p 48
###begin p 49
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 7 8 7 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
cTrend P value was estimated by Cox regression analysis
###end p 49
###begin title 50
DBP Haplotype 1 and Dietary Calcium Intake in Osteoporosis
###end title 50
###begin p 51
###xml 17 18 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 218 219 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 245 246 245 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 721 722 721 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 730 731 730 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1066 1067 1066 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1169 1175 1169 1175 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1732 1733 1732 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1803 1804 1803 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1814 1815 1814 1815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1175 1906 1175 1906 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="52">Interaction of DBP haplotype 1 and dietary calcium intake for the risk of osteoporosis. We applied different ways to stratify calcium intake categories as median (low vs. high), tertiles, and quartiles. In each stratification analysis, the hazard ratio (adjusted for age and gender) was calculated by using noncarrier of DBP haplotype 1 as the reference category. In the low calcium intake (&lt;1.09&#160;g/day) group, we observed that the clinical fracture risk increased with increased number of the DBP haplotype 1 and that those homozygous for DBP haplotype 1 (<italic>n</italic>&#160;=&#160;774) had a 47% increased risk of fracture compared to noncarriers (<italic>n</italic>&#160;=&#160;439, *&#160;<italic>P</italic>&#160;=&#160;0.02). A similar relationship between DBP haplotype 1 and clinical fracture was observed</p>
###xml 1175 1906 1175 1906 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="52">Interaction of DBP haplotype 1 and dietary calcium intake for the risk of osteoporosis. We applied different ways to stratify calcium intake categories as median (low vs. high), tertiles, and quartiles. In each stratification analysis, the hazard ratio (adjusted for age and gender) was calculated by using noncarrier of DBP haplotype 1 as the reference category. In the low calcium intake (&lt;1.09&#160;g/day) group, we observed that the clinical fracture risk increased with increased number of the DBP haplotype 1 and that those homozygous for DBP haplotype 1 (<italic>n</italic>&#160;=&#160;774) had a 47% increased risk of fracture compared to noncarriers (<italic>n</italic>&#160;=&#160;439, *&#160;<italic>P</italic>&#160;=&#160;0.02). A similar relationship between DBP haplotype 1 and clinical fracture was observed</p></caption>
###xml 1906 1906 1906 1906 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="223_2009_9251_Fig2_HTML" id="MO2"/>
###xml 1169 1906 1169 1906 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="52">Interaction of DBP haplotype 1 and dietary calcium intake for the risk of osteoporosis. We applied different ways to stratify calcium intake categories as median (low vs. high), tertiles, and quartiles. In each stratification analysis, the hazard ratio (adjusted for age and gender) was calculated by using noncarrier of DBP haplotype 1 as the reference category. In the low calcium intake (&lt;1.09&#160;g/day) group, we observed that the clinical fracture risk increased with increased number of the DBP haplotype 1 and that those homozygous for DBP haplotype 1 (<italic>n</italic>&#160;=&#160;774) had a 47% increased risk of fracture compared to noncarriers (<italic>n</italic>&#160;=&#160;439, *&#160;<italic>P</italic>&#160;=&#160;0.02). A similar relationship between DBP haplotype 1 and clinical fracture was observed</p></caption><graphic position="anchor" xlink:href="223_2009_9251_Fig2_HTML" id="MO2"/></fig>
In the subgroup (n = 4,747) with a record of dietary calcium intake, we observed a similar trend (compared to the entire study population) and a borderline significant association of DBP haplotype 1 and fracture risk (P = 0.06). The interaction P value between the DBP haplotype 1 genotype and dietary calcium intake for clinical fracture was 0.05 after adjustment for age and gender. We then investigated the relationship between DBP haplotype 1 and clinical fracture risk after stratification of the median dietary calcium intake. In the low dietary calcium intake (<1.09 g/day) group, we found that subjects homozygous for DBP haplotype 1 (n = 774) had 47% increased risk of clinical fracture compared to noncarriers (n = 439, P = 0.02). The association remained when we adjusted for age and gender. In the high dietary calcium intake group no association was found. We also stratified calcium intake as tertiles and quartiles, and similar patterns of increased fracture risk by DBP haplotype 1 were observed in those with a relatively lower calcium intake (Fig. 2). No interaction between DBP genotype and calcium intake for BMD and serum vitamin D level was found.Fig. 2Interaction of DBP haplotype 1 and dietary calcium intake for the risk of osteoporosis. We applied different ways to stratify calcium intake categories as median (low vs. high), tertiles, and quartiles. In each stratification analysis, the hazard ratio (adjusted for age and gender) was calculated by using noncarrier of DBP haplotype 1 as the reference category. In the low calcium intake (<1.09 g/day) group, we observed that the clinical fracture risk increased with increased number of the DBP haplotype 1 and that those homozygous for DBP haplotype 1 (n = 774) had a 47% increased risk of fracture compared to noncarriers (n = 439, * P = 0.02). A similar relationship between DBP haplotype 1 and clinical fracture was observed
###end p 51
###begin p 52
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 628 629 628 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 639 640 639 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Interaction of DBP haplotype 1 and dietary calcium intake for the risk of osteoporosis. We applied different ways to stratify calcium intake categories as median (low vs. high), tertiles, and quartiles. In each stratification analysis, the hazard ratio (adjusted for age and gender) was calculated by using noncarrier of DBP haplotype 1 as the reference category. In the low calcium intake (<1.09 g/day) group, we observed that the clinical fracture risk increased with increased number of the DBP haplotype 1 and that those homozygous for DBP haplotype 1 (n = 774) had a 47% increased risk of fracture compared to noncarriers (n = 439, * P = 0.02). A similar relationship between DBP haplotype 1 and clinical fracture was observed
###end p 52
###begin p 53
No interaction between DBP or VDR genotypes in relation to vitamin D level or BMD was observed in our study population (data not shown).
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
In this study we observed that haplotypes of DBP (corresponding to isoforms of Gc protein) are associated with differences in serum vitamin D level. In addition, we observed a genetic effect of the DBP gene on fracture risk, especially at low dietary calcium intake or in combination with an osteoporosis-risk allele of the VDR gene.
###end p 55
###begin p 56
###xml 419 420 419 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
Together with other environmental and genetic factors, variation in DBP activity can contribute to the pathological progress of osteoporosis by the regulation of calcium metabolism in blood and bone. The protein and genomic structures reveal at least two separate functions of the DBP in bone remodeling. The vitamin D binding region of DBP is located between residues 35 and 49 at the N-terminal end (domain I in Fig. 1) [9]. Domains II and III are responsible for the non-sterol binding activities of DBP [15]. The macrophage/osteoclast activating activity is also related to domain III [14, 15]. The glycosylation of DBP in domain III is important for macrophage and osteoclast activation, while it has been shown that binding of vitamin D does not influence this activity [30]. This indicates that domain III plays an independent role from domain I (vitamin D binding domain) in the function of stimulating osteoclast activity. Two SNPs are located in the C-terminal end (domain III, from residue 375 to the end) with a single glycosylation site nearby. Our LD structure analysis of the DBP locus showed that domains I and III (the latter containing the two SNPs) are in different haplotype blocks. This indicates that all observed associations and interactions with the studied polymorphisms are independent of polymorphisms in the region corresponding to domain I.
###end p 56
###begin p 57
###xml 143 144 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 157 158 157 158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 159 160 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 274 275 274 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 288 289 288 289 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 290 291 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 521 522 521 522 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 572 577 <span type="species:ncbi:9606">women</span>
The classical function of DBP is to store and prolong the half-life of circulating vitamin D metabolites. DBP binds 88 and 85% of serum 25(OH)D3 and 1,25(OH)2D3, respectively [9]. In our study, haplotype 1 (corresponding to Gc1 s) was positively correlated with both 25(OH)D3 and 1,25(OH)2D3, while haplotype 2 (Gc2) was negatively correlated. Lauridsen et al. [31] demonstrated that Gc1 (consisting of 80% haplotype 1/Gc1s and 20% haplotype 3/Gc1f in our analysis) was associated with 8.5 nmol/l increased plasma 25(OH)D3 and DBP level in Danish Caucasian postmenopausal women, and DBP Gc2 was negatively correlated to plasma vitamin D and DBP level. Thus, our finding of a relationship between haplotype 1 and vitamin D level is in line with a previous report in Caucasians [12].
###end p 57
###begin p 58
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
A relationship of Gc1 and increased fracture risk was reported by Lauridsen et al. [22, 31]. This relationship cannot be explained by the effect of DBP on the vitamin D endocrine system since increased total vitamin D is not associated with increased fracture risk. Only free vitamin D hormone, which is only <12-15% of the total vitamin D level, has biological activity, rather than bound hormone [32]. Thus, the observed relationship between DBP and fracture risk could result from the function of DBP-MAF in bone resorption.
###end p 58
###begin p 59
###xml 210 211 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 933 935 933 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 1197 1199 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 1201 1203 1201 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 1479 1480 1479 1480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1109 1113 <span type="species:ncbi:10116">rats</span>
We did not observe a significant association between DBP genotype and fracture risk in the complete study population, although a modest trend for DBP haplotype 1 (Gc1s) associated with increased fracture risk (P = 0.13) was apparent. However, this association was stronger in subjects with relatively low dietary calcium intake (<1.09 g/day) in this Dutch Caucasian population. We note that Lauridsen et al. [22] showed a similar relationship between Gc1 and fracture risk in a population of Danish Caucasians with a dietary calcium intake of 0.8 g/day level [31]. Another study, in a Japanese population [21], found the Glu allele at codon 416 (corresponding to our DBP haplotype 1) to be associated with decreased radial BMD. The dietary calcium intake of Japanese populations is considered to be even lower (0.6 g/day) [33] than ours and the Danish study populations. DBP haplotype 1 is associated with increased serum DBP level [31] and might also be associated with increased DBP-MAF level. DBP-MAF is an activator of osteoclasts, while in vivo studies have demonstrated that a calcium-deficient diet in rats could significantly increase the number of osteoclasts in different sites of bone [18, 19], which results in increasing bone resorption and releasing calcium into blood to maintain serum calcium at a stable level. We also analyzed subjects with dietary calcium intake <0.6 g/day for DBP-related differences in BMD, but low statistical power in this small subgroup (n = 147) prevented any conclusion being drawn.
###end p 59
###begin p 60
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
In this study we also demonstrated an association between VDR block 5-haplotype 1 and fracture risk, especially in the group of DBP haplotype 1 carriers. This gene-gene interaction on fracture risk reflects two aspects of bone (re)modeling, which include bone formation (by osteoblasts) and bone resorption (by osteoclasts) to maintain serum calcium homeostasis and bone metabolism. Vitamin D stimulates bone formation [34]. On the one hand, VDR block 5-haplotype 1, a fracture risk allele, results in lower expression of VDR mRNA in osteoblasts [13]. This indicates that the osteoblast of VDR block 5-haplotype 1 carriers could give a compromised response to vitamin D since lower numbers of VDR protein are present in the target cells. This likely results in lower bone formation for VDR block 5-haplotype 1 carriers. On the other hand, DBP haplotype 1 is associated with increased DBP level, and this might result in increasing osteoclast activity and increasing bone resorption. Taken together, subjects with both fracture-risk alleles might have a lower bone formation and higher bone resorption and thereby increased bone turnover, which negatively influences bone quality and strength [35], with fracture risk consequently increasing. This hypothesis obviously needs to be tested by more detailed functionality studies.
###end p 60
###begin p 61
We had excellent power (100%) to detect our gene-gene and gene-environmental interaction effect on the fracture risk in our large population. Although we did not observe an association of DBP genotype and fracture risk, we still had good statistical power (>80%) to detect a real association if it existed in our studies. One limitation of the study was that, though most findings of our current study were from the same population, different findings were based on different subjects due to incomplete data for every individual in the large population.
###end p 61
###begin p 62
We conclude that the genetic effect of the DBP haplotypes as defined by two SNPs (E416D and T420K) together with VDR genotype on fracture risk is independent of the vitamin D binding domain of the DBP protein. The modest genetic effect of the DBP gene on fracture risk is only apparent when other genetic (e.g., risk allele of the VDR gene) and environmental (e.g., low calcium intake) cofactors are present. This suggests that those genetic and environmental factors might affect bone turnover and consequently increase fracture risk.
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
###xml 13 25 <span type="species:ncbi:9606">participants</span>
We thank all participants of the Rotterdam Study and the general practitioners, pharmacists, and many fieldworkers at the research center in the Netherlands. We thank C. J. Buurman for performing the serum vitamin D measurements. This project was funded by the Dutch Research Organisation (NWO 903-46-178, 925-01-010, 014-90-001, and 911-03-012) and the European Commission under grant QLK6-CT-2002-02629 (GENOMOS).
###end p 64
###begin p 65
###xml 0 11 0 11 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Open Access</bold>
Open Access This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density
###end article-title 67
###begin article-title 68
###xml 128 133 <span type="species:ncbi:9606">women</span>
Relation of alleles of the collagen type I alpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women
###end article-title 68
###begin article-title 69
Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk
###end article-title 69
###begin article-title 70
###xml 49 54 <span type="species:ncbi:9606">human</span>
Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly
###end article-title 70
###begin article-title 71
Polymorphisms of the interleukin-6 gene are associated with bone mineral density
###end article-title 71
###begin article-title 72
Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes
###end article-title 72
###begin article-title 73
Vitamin D and bone health in the elderly
###end article-title 73
###begin article-title 74
The multifunctional properties and characteristics of vitamin D-binding protein
###end article-title 74
###begin article-title 75
###xml 51 55 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein
###end article-title 75
###begin article-title 76
Vitamin D metabolites in childhood nephrotic syndrome
###end article-title 76
###begin article-title 77
Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration
###end article-title 77
###begin article-title 78
Promoter and 3'-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam Study
###end article-title 78
###begin article-title 79
Plasma vitamin D-binding protein (Gc-globulin): multiple tasks
###end article-title 79
###begin article-title 80
Molecular recognition in vitamin D-binding protein
###end article-title 80
###begin article-title 81
Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis
###end article-title 81
###begin article-title 82
Effects of vitamin D binding protein-macrophage activating factor (DBP-MAF) infusion on bone resorption in two osteopetrotic mutations
###end article-title 82
###begin article-title 83
Differential response in alveolar bone osteoclasts residing at two different bone sites
###end article-title 83
###begin article-title 84
###xml 105 108 <span type="species:ncbi:10116">rat</span>
Osteoclast recruitment and modulation by calcium deficiency, fasting, and calcium supplementation in the rat
###end article-title 84
###begin article-title 85
###xml 39 44 <span type="species:ncbi:9606">human</span>
Molecular analysis of the gene for the human vitamin-D-binding protein (group-specific component): allelic differences of the common genetic GC types
###end article-title 85
###begin article-title 86
###xml 85 90 <span type="species:ncbi:9606">human</span>
Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density
###end article-title 86
###begin article-title 87
Female premenopausal fracture risk is associated with gc phenotype
###end article-title 87
###begin article-title 88
Determinants of disease and disability in the elderly: the Rotterdam Elderly Study
###end article-title 88
###begin article-title 89
###xml 56 59 <span type="species:ncbi:9606">men</span>
###xml 64 69 <span type="species:ncbi:9606">women</span>
The association between age and bone mineral density in men and women aged 55 years and over: the Rotterdam Study
###end article-title 89
###begin article-title 90
The assessment of vertebral deformity: a method for use in population studies and clinical trials
###end article-title 90
###begin article-title 91
###xml 40 43 <span type="species:ncbi:9606">men</span>
###xml 48 53 <span type="species:ncbi:9606">women</span>
The incidence of vertebral fractures in men and women: the Rotterdam Study
###end article-title 91
###begin article-title 92
###xml 143 144 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
Baculovirus-expressed vitamin D-binding protein-macrophage activating factor (DBP-MAF) activates osteoclasts and binding of 25-hydroxyvitamin D3 does not influence this activity
###end article-title 92
###begin article-title 93
###xml 191 196 <span type="species:ncbi:9606">women</span>
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women
###end article-title 93
###begin article-title 94
The free hormone hypothesis: a physiologically based mathematical model
###end article-title 94
###begin article-title 95
Relationship between dietary calcium and bone mineral density before menopause [in Japanese]
###end article-title 95
###begin article-title 96
###xml 104 109 <span type="species:ncbi:9606">human</span>
Evidence for auto/paracrine actions of vitamin D in bone: 1alpha-hydroxylase expression and activity in human bone cells
###end article-title 96
###begin article-title 97
###xml 90 95 <span type="species:ncbi:9606">women</span>
Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial
###end article-title 97

